<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Fluoxetine,Antidepressants,ATC code N06,Adrenergic antagonist,Adrenergic uptake inhibitor,Adverse drug reaction,Agomelatine,Akathisia,Alaproclate,Alpha-2 adrenergic receptor,Amineptine" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Fluoxetine&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Fluoxetine&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Fluoxetine - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Fluoxetine";
		var wgTitle = "Fluoxetine";
		var wgAction = "view";
		var wgArticleId = "10153680";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 281743162;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Fluoxetine skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Fluoxetine</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<div class="dablink">"Prozac" redirects here. For other uses, see <a href="/wiki/Prozac_(disambiguation)" title="Prozac (disambiguation)">Prozac (disambiguation)</a>.</div>
<table id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" class="toccolours" border="0" cellpadding="1" align="right" width="280">
<tr>
<td align="center" colspan="2"><a href="/wiki/File:Fluoxetine-2D-skeletal.svg" class="image" title="Fluoxetine-2D-skeletal.svg"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/9/9c/Fluoxetine-2D-skeletal.svg/200px-Fluoxetine-2D-skeletal.svg.png" width="200" height="100" border="0" /></a></td>
</tr>
<tr>
<td align="center" colspan="2"><a href="/wiki/File:S-fluoxetine-3D-vdW.png" class="image" title="S-fluoxetine-3D-vdW.png"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/f/f5/S-fluoxetine-3D-vdW.png/200px-S-fluoxetine-3D-vdW.png" width="200" height="132" border="0" /></a></td>
</tr>
<tr>
<td align="center" colspan="2">
<div style="font-size:medium; line-height:167%;">Fluoxetine</div>
</td>
</tr>
<tr>
<td align="center" colspan="2" bgcolor="#DDDDDD"><b>Systematic (<a href="/wiki/International_Union_of_Pure_and_Applied_Chemistry_nomenclature" title="International Union of Pure and Applied Chemistry nomenclature" class="mw-redirect">IUPAC</a>) name</b></td>
</tr>
<tr>
<td bgcolor="#EEEEEE" style="text-align: center; vertical-align: top;" colspan="2"><span style="font-size:11px"><i>N</i>-methyl-3-phenyl-3-[4- (trifluoromethyl)phenoxy]propan-1-amine</span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Identifiers</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" width="90"><a href="/wiki/CAS_registry_number" title="CAS registry number">CAS number</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=54910-89-3&amp;rn=1" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=54910-89-3&amp;rn=1" rel="nofollow">54910-89-3</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></td>
<td bgcolor="#EEEEEE"><a href="/wiki/ATC_code_N06" title="ATC code N06">N06</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N06AB03" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N06AB03" rel="nofollow">AB03</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/PubChem" title="PubChem">PubChem</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=3386" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=3386" rel="nofollow">3386</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/DrugBank" title="DrugBank">DrugBank</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.drugbank.ca/cgi-bin/show_drug.cgi?CARD=APRD00530" class="external text" title="http://www.drugbank.ca/cgi-bin/show_drug.cgi?CARD=APRD00530" rel="nofollow">APRD00530</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/ChemSpider" title="ChemSpider">ChemSpider</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.chemspider.com/Chemical-Structure.56589" class="external text" title="http://www.chemspider.com/Chemical-Structure.56589" rel="nofollow">56589</a></span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Chemical data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Chemical_formula" title="Chemical formula">Formula</a></td>
<td bgcolor="#EEEEEE"><a href="/wiki/Carbon" title="Carbon"><span style="color: rgb(000,000,000); font-weight: bold;">C</span></a><sub>17</sub><a href="/wiki/Hydrogen" title="Hydrogen"><span style="color: rgb(77,77,77); font-weight: bold;">H</span></a><sub>18</sub><a href="/wiki/Fluorine" title="Fluorine"><span style="color: rgb(66,98,98); font-weight: bold;">F</span></a><sub>3</sub><a href="/wiki/Nitrogen" title="Nitrogen"><span style="color: rgb(0,0,128); font-weight: bold;">N</span></a><a href="/wiki/Oxygen" title="Oxygen"><span style="color: rgb(116,35,35); font-weight: bold;">O</span></a><sup>&#160;</sup></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Molecular_mass" title="Molecular mass">Mol. mass</a></td>
<td bgcolor="#EEEEEE">309.3 g/mol (345.8 for •HCl)</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Pharmacokinetic data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Bioavailability" title="Bioavailability">Bioavailability</a></td>
<td bgcolor="#EEEEEE">72%<br />
peak at 6-8 hours</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Plasma_protein_binding" title="Plasma protein binding">Protein binding</a></td>
<td bgcolor="#EEEEEE">94.5%</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Drug_metabolism" title="Drug metabolism">Metabolism</a></td>
<td bgcolor="#EEEEEE">Hepatic</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Biological_half-life" title="Biological half-life">Half life</a></td>
<td bgcolor="#EEEEEE">1-3 days (acute); 4-6 days (chronic); Active metabolite Norfluoxetine 4-16 days (acute and chronic)</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Excretion" title="Excretion">Excretion</a></td>
<td bgcolor="#EEEEEE">Kidneys 80%, intestines 15%</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Therapeutic considerations</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Licence data</a></td>
<td bgcolor="#EEEEEE">
<p><a href="/wiki/European_Medicines_Agency" title="European Medicines Agency">EU EMEA</a>:<span class="reflink plainlinksneverexpand"><a href="http://www.emea.europa.eu/humandocs/Humans/EPAR/Fluoxetine/Fluoxetine.htm" class="external text" title="http://www.emea.europa.eu/humandocs/Humans/EPAR/Fluoxetine/Fluoxetine.htm" rel="nofollow">link</a></span>,&#160;<a href="/wiki/U.S._Food_and_Drug_Administration" title="U.S. Food and Drug Administration">US FDA</a>:<span class="reflink plainlinksneverexpand"><a href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;SearchTerm=Fluoxetine&amp;SearchType=BasicSearch" class="external text" title="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;SearchTerm=Fluoxetine&amp;SearchType=BasicSearch" rel="nofollow">link</a></span></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Pregnancy_category" title="Pregnancy category">Pregnancy cat.</a></td>
<td bgcolor="#EEEEEE">
<p>C<small>(<a href="/wiki/Australia" title="Australia">AU</a>)</small> C<small>(<a href="/wiki/United_States" title="United States">US</a>)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Legal status</a></td>
<td bgcolor="#EEEEEE">
<p><span class="Unicode">℞</span> P<small>rescription only</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Route_of_administration" title="Route of administration">Routes</a></td>
<td bgcolor="#EEEEEE"><a href="/wiki/Mouth" title="Mouth">Oral</a></td>
</tr>
</table>
<div class="thumb tright">
<div class="thumbinner" style="width:252px;"><a href="/wiki/File:Prozac_pills.jpg" class="image" title="Prozac pills"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Prozac_pills.jpg/250px-Prozac_pills.jpg" width="250" height="188" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Prozac_pills.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Prozac pills</div>
</div>
</div>
<p><b>Fluoxetine hydrochloride</b> (trade names <b>Prozac</b>, <b>Fontex</b>, <b>Ladose</b>, <b>Sarafem</b>, <b>Solax</b>, <b>Lovan</b>) is an <a href="/wiki/Antidepressant" title="Antidepressant">antidepressant</a> of the <a href="/wiki/Selective_serotonin_reuptake_inhibitor" title="Selective serotonin reuptake inhibitor">selective serotonin reuptake inhibitor</a> (SSRI) class. Fluoxetine is approved for the treatment of <a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">major depression</a> (including pediatric depression), <a href="/wiki/Obsessive-compulsive_disorder" title="Obsessive-compulsive disorder">obsessive-compulsive disorder</a> (in both adult and pediatric populations), <a href="/wiki/Bulimia_nervosa" title="Bulimia nervosa">bulimia nervosa</a>, <a href="/wiki/Anorexia_nervosa" title="Anorexia nervosa">anorexia nervosa</a>, <a href="/wiki/Panic_disorder" title="Panic disorder">panic disorder</a> and <a href="/wiki/Premenstrual_dysphoric_disorder" title="Premenstrual dysphoric disorder">premenstrual dysphoric disorder</a>.<sup id="cite_ref-RxList_0-0" class="reference"><a href="#cite_note-RxList-0" title=""><span>[</span>1<span>]</span></a></sup> Despite the availability of newer agents, it remains extremely popular. Over 22.2 million prescriptions for generic formulations of fluoxetine were filled in the United States in 2007, making it the third most prescribed antidepressant.<sup id="cite_ref-1" class="reference"><a href="#cite_note-1" title=""><span>[</span>2<span>]</span></a></sup></p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">1</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1"><a href="#Indications"><span class="tocnumber">2</span> <span class="toctext">Indications</span></a></li>
<li class="toclevel-1"><a href="#Pharmacokinetics"><span class="tocnumber">3</span> <span class="toctext">Pharmacokinetics</span></a></li>
<li class="toclevel-1"><a href="#Adverse_effects"><span class="tocnumber">4</span> <span class="toctext">Adverse effects</span></a>
<ul>
<li class="toclevel-2"><a href="#Discontinuation_syndrome"><span class="tocnumber">4.1</span> <span class="toctext">Discontinuation syndrome</span></a></li>
<li class="toclevel-2"><a href="#Suicidality_in_antidepressant_trials"><span class="tocnumber">4.2</span> <span class="toctext">Suicidality in antidepressant trials</span></a></li>
<li class="toclevel-2"><a href="#Suicidality_and_fluoxetine"><span class="tocnumber">4.3</span> <span class="toctext">Suicidality and fluoxetine</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Interactions"><span class="tocnumber">5</span> <span class="toctext">Interactions</span></a></li>
<li class="toclevel-1"><a href="#Controversy"><span class="tocnumber">6</span> <span class="toctext">Controversy</span></a></li>
<li class="toclevel-1"><a href="#Prozac_in_popular_culture"><span class="tocnumber">7</span> <span class="toctext">Prozac in popular culture</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">8</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">9</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Fluoxetine&amp;action=edit&amp;section=1" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<p>According to David Wong,<sup id="cite_ref-Wong_2-0" class="reference"><a href="#cite_note-Wong-2" title=""><span>[</span>3<span>]</span></a></sup> the work which eventually led to the discovery of fluoxetine began at <a href="/wiki/Eli_Lilly" title="Eli Lilly">Eli Lilly</a> in 1970 as a collaboration between Bryan Molloy and Robert Rathbun. It was known at that time that the <a href="/wiki/Antihistamine" title="Antihistamine" class="mw-redirect">antihistamine</a> <a href="/wiki/Diphenhydramine" title="Diphenhydramine">diphenhydramine</a> shows some antidepressant-like properties. 3-Phenoxy-3-phenylpropylamine, a compound structurally similar to diphenhydramine, was taken as a starting point, and Molloy synthesized dozens of its derivatives. Testing the physiological effects of these compounds in mice resulted in <a href="/wiki/Nisoxetine" title="Nisoxetine">nisoxetine</a>, a selective <a href="/wiki/Norepinephrine_reuptake_inhibitor" title="Norepinephrine reuptake inhibitor">norepinephrine reuptake inhibitor</a> currently widely used in biochemical experiments.<sup id="cite_ref-Wong_2-1" class="reference"><a href="#cite_note-Wong-2" title=""><span>[</span>3<span>]</span></a></sup></p>
<p>Later, hoping to find a derivative inhibiting only <a href="/wiki/Serotonin" title="Serotonin">serotonin</a> reuptake, Wong proposed to re-test the series for the <a href="/wiki/In-vitro" title="In-vitro" class="mw-redirect">in-vitro</a> reuptake of serotonin, norepinephrine and <a href="/wiki/Dopamine" title="Dopamine">dopamine</a>. This test, carried out by Jong-Sir Horng in May 1972,<sup id="cite_ref-Wong_2-2" class="reference"><a href="#cite_note-Wong-2" title=""><span>[</span>3<span>]</span></a></sup> showed the compound later named fluoxetine to be the most potent and selective inhibitor of serotonin reuptake of the series.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3" title=""><span>[</span>4<span>]</span></a></sup></p>
<p>A controversy ensued after Lilly researchers published a paper entitled "Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug"<sup id="cite_ref-Wong_2-3" class="reference"><a href="#cite_note-Wong-2" title=""><span>[</span>3<span>]</span></a></sup> claiming fluoxetine to be the first <a href="/wiki/Selective_serotonin_reuptake_inhibitor" title="Selective serotonin reuptake inhibitor">selective serotonin reuptake inhibitor</a> (SSRI). Two years later they had to issue a correction, admitting that the first SSRI was <a href="/wiki/Zimelidine" title="Zimelidine">zimelidine</a> developed by <a href="/wiki/Arvid_Carlsson" title="Arvid Carlsson">Arvid Carlsson</a> and colleagues.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4" title=""><span>[</span>5<span>]</span></a></sup> Fluoxetine made its appearance on the Belgian market in 1986<sup id="cite_ref-5" class="reference"><a href="#cite_note-5" title=""><span>[</span>6<span>]</span></a></sup> and was approved for use by the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration" class="mw-redirect">FDA</a> in the United States in December 1987.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6" title=""><span>[</span>7<span>]</span></a></sup> Fluoxetine was the fourth SSRI to make it to market, after <a href="/wiki/Zimelidine" title="Zimelidine">zimelidine</a>, <a href="/wiki/Indalpine" title="Indalpine">indalpine</a> and <a href="/wiki/Fluvoxamine" title="Fluvoxamine">fluvoxamine</a>. However, the first two were withdrawn due to the side effects, and a vigorous marketing campaign by Eli Lilly made sure that in the popular culture fluoxetine has been perceived as a scientific breakthrough and associated with the title of the first SSRI.</p>
<p><a href="/wiki/Eli_Lilly" title="Eli Lilly">Eli Lilly</a>'s patent on Prozac (fluoxetine) expired in August, 2001,<sup id="cite_ref-7" class="reference"><a href="#cite_note-7" title=""><span>[</span>8<span>]</span></a></sup> prompting an influx of generic drugs onto the market.</p>
<p><a name="Indications" id="Indications"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Fluoxetine&amp;action=edit&amp;section=2" title="Edit section: Indications">edit</a>]</span> <span class="mw-headline">Indications</span></h2>
<p>Fluoxetine has been approved by the FDA for the treatment of <a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">major depression</a>, <a href="/wiki/Obsessive_compulsive_disorder" title="Obsessive compulsive disorder" class="mw-redirect">obsessive compulsive disorder</a>, <a href="/wiki/Bulimia_nervosa" title="Bulimia nervosa">bulimia nervosa</a> and <a href="/wiki/Panic_disorder" title="Panic disorder">panic disorder</a>.<sup id="cite_ref-prozacpi_8-0" class="reference"><a href="#cite_note-prozacpi-8" title=""><span>[</span>9<span>]</span></a></sup> Fluoxetine was shown to be effective for depression in 6-week long double-blind controlled trials where it also alleviated anxiety and improved sleep. Fluoxetine was better than placebo for the prevention of depression recurrence when the patients, who originally responded to fluoxetine, were treated for a further 38 weeks. Efficacy of fluoxetine for geriatric as well as pediatric depression was also demonstrated in placebo-controlled trials.<sup id="cite_ref-prozacpi_8-1" class="reference"><a href="#cite_note-prozacpi-8" title=""><span>[</span>9<span>]</span></a></sup></p>
<p>The peculiar pharmacokinetics of fluoxetine with its brain levels rising extremely slowly over at least first 5 weeks of treatment (see <a href="#Pharmacokinetics" title="">Pharmacokinetics</a>) makes it unclear whether the 20-mg/day optimal dose established in the short term (6-8 weeks) trials is applicable for the longer term supportive treatment. One 60-mg dose of fluoxetine per week was found to be equivalent to 20 mg/day for the continuation treatment of responders to 20 mg/day of fluoxetine.<sup id="cite_ref-pmid8927671_9-0" class="reference"><a href="#cite_note-pmid8927671-9" title=""><span>[</span>10<span>]</span></a></sup><sup id="cite_ref-pmid10917403_10-0" class="reference"><a href="#cite_note-pmid10917403-10" title=""><span>[</span>11<span>]</span></a></sup> Furthermore, 5 mg/day fluoxetine was shown to be better than placebo and similar to 20 mg/day,<sup id="cite_ref-pmid7935707_11-0" class="reference"><a href="#cite_note-pmid7935707-11" title=""><span>[</span>12<span>]</span></a></sup> and one weekly dose of 80 mg fluoxetine was equivalent to 60 mg/day fluoxetine or 150 mg/day <a href="/wiki/Amitriptyline" title="Amitriptyline">amitriptyline</a>.<sup id="cite_ref-pmid10917403_10-1" class="reference"><a href="#cite_note-pmid10917403-10" title=""><span>[</span>11<span>]</span></a></sup> On the other hand, increase of the dose to 60 mg/day in non-responders from 20 mg/day brought no additional benefits as compared to continuing the 20 mg/day treatment.<sup id="cite_ref-pmid7935707_11-1" class="reference"><a href="#cite_note-pmid7935707-11" title=""><span>[</span>12<span>]</span></a></sup></p>
<p>The recent research suggests that a significant part of the resistance to the SSRIs <a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a> (Paxil) and <a href="/wiki/Citalopram" title="Citalopram">citalopram</a> (Celexa) can be explained by the <a href="/wiki/Genetic_variation" title="Genetic variation" class="mw-redirect">genetic variation</a> of <a href="/wiki/P-glycoprotein" title="P-glycoprotein">Pgp</a> transporter. Paroxetine and citalopram, which are Pgp substrates, are actively transported from the brain by this protein. Fluoxetine is not a substrate of Pgp, and thus a switch from paroxetine or citalopram to fluoxetine may be beneficial to the non-responders.<sup id="cite_ref-pmid18215618_12-0" class="reference"><a href="#cite_note-pmid18215618-12" title=""><span>[</span>13<span>]</span></a></sup><sup id="cite_ref-pmid17913323_13-0" class="reference"><a href="#cite_note-pmid17913323-13" title=""><span>[</span>14<span>]</span></a></sup></p>
<p><a href="/wiki/Obsessive-compulsive_disorder" title="Obsessive-compulsive disorder">OCD</a> was successfully treated by fluoxetine in two adult and one pediatric placebo-controlled 13-week trials. The higher doses of fluoxetine appeared to result in better response, while the reverse relationship was observed in the treatment of depression.<sup id="cite_ref-prozacpi_8-2" class="reference"><a href="#cite_note-prozacpi-8" title=""><span>[</span>9<span>]</span></a></sup> Fluoxetine dramatically, by 40-50%, decreased the frequency of panic attacks in two controlled trials of panic disorder patients. In three double-blind trials fluoxetine significantly decreased the number of <a href="/wiki/Binge_eating" title="Binge eating">binge-eating</a> and purging episodes of <a href="/wiki/Bulimia_nervosa" title="Bulimia nervosa">bulimia nervosa</a>. Continued year-long treatment of the patients, who originally responded to fluoxetine, was more effective than placebo for the prevention of bulimia nervosa episodes.<sup id="cite_ref-prozacpi_8-3" class="reference"><a href="#cite_note-prozacpi-8" title=""><span>[</span>9<span>]</span></a></sup></p>
<p><a name="Pharmacokinetics" id="Pharmacokinetics"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Fluoxetine&amp;action=edit&amp;section=3" title="Edit section: Pharmacokinetics">edit</a>]</span> <span class="mw-headline">Pharmacokinetics</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:CYP2D6_structure.png" class="image" title="3 dimensional representation of the cytochrome P450 isoenzyme CYP2D6. CYP2D6 is responsible for converting fluoxetine to its only active metabolite, norfluoxetine.[15] Both drugs are also potent inhibitors of CYP2D6.[16]"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/a/ab/CYP2D6_structure.png/180px-CYP2D6_structure.png" width="180" height="135" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:CYP2D6_structure.png" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
3 dimensional representation of the <a href="/wiki/Cytochrome_P450" title="Cytochrome P450">cytochrome P450</a> <a href="/wiki/Isoenzyme" title="Isoenzyme" class="mw-redirect">isoenzyme</a> <a href="/wiki/CYP2D6" title="CYP2D6">CYP2D6</a>. CYP2D6 is responsible for converting fluoxetine to its only active metabolite, norfluoxetine.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14" title=""><span>[</span>15<span>]</span></a></sup> Both drugs are also potent <a href="/wiki/Enzyme_inhibitor" title="Enzyme inhibitor">inhibitors</a> of CYP2D6.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15" title=""><span>[</span>16<span>]</span></a></sup></div>
</div>
</div>
<p>The <a href="/wiki/Bioavailability" title="Bioavailability">bioavailability</a> of fluoxetine is relatively high (72%), and peak plasma concentrations are reached in 6 to 8 hours. It is highly <a href="/wiki/Plasma_protein_binding" title="Plasma protein binding">bound</a> to plasma proteins, mostly <a href="/wiki/Human_serum_albumin" title="Human serum albumin">albumin</a>.</p>
<p>Fluoxetine is <a href="/wiki/Drug_metabolism" title="Drug metabolism">metabolized</a> in the <a href="/wiki/Liver" title="Liver">liver</a> by <a href="/wiki/Isoenzyme" title="Isoenzyme" class="mw-redirect">isoenzymes</a> of the <a href="/wiki/Cytochrome_P450" title="Cytochrome P450">cytochrome P450</a> system, including <a href="/wiki/CYP2D6" title="CYP2D6">CYP2D6</a>.<sup id="cite_ref-RxList_0-1" class="reference"><a href="#cite_note-RxList-0" title=""><span>[</span>1<span>]</span></a></sup> The role of CYP2D6 in the <a href="/wiki/Metabolism" title="Metabolism">metabolism</a> of fluoxetine may be clinically important, as there is great <a href="/wiki/Genetic_variability" title="Genetic variability">genetic variability</a> in the function of this enzyme among people. Only one <a href="/wiki/Metabolite" title="Metabolite">metabolite</a> of fluoxetine, <i>norfluoxetine</i> (<a href="/wiki/Demethylation" title="Demethylation">demethylated</a> fluoxetine), is biologically active.</p>
<p>The extremely slow elimination of fluoxetine and its active metabolite norfluoxetine from the body distinguishes it from other antidepressants. With time, fluoxetine and norfluoxetine inhibit their own metabolism, so fluoxetine <a href="/wiki/Elimination_half-life" title="Elimination half-life" class="mw-redirect">elimination half-life</a> changes from 1 to 3 days, after a single dose—to 4 to 6 days, after long-term use. Similarly, the half-life of norfluoxetine is longer (16 days) after long-term use.<sup id="cite_ref-RxList_0-2" class="reference"><a href="#cite_note-RxList-0" title=""><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Newcastle_16-0" class="reference"><a href="#cite_note-Newcastle-16" title=""><span>[</span>17<span>]</span></a></sup><sup id="cite_ref-pmid10917403_10-2" class="reference"><a href="#cite_note-pmid10917403-10" title=""><span>[</span>11<span>]</span></a></sup> Therefore, the concentration of the drug and its active metabolite in the blood continues to grow through the first few weeks of treatment, and their steady concentration in the blood is achieved only after four weeks.<sup id="cite_ref-pmid11199945_17-0" class="reference"><a href="#cite_note-pmid11199945-17" title=""><span>[</span>18<span>]</span></a></sup><sup id="cite_ref-pmid12063152_18-0" class="reference"><a href="#cite_note-pmid12063152-18" title=""><span>[</span>19<span>]</span></a></sup> Moreover, the brain concentration of fluoxetine and its metabolites keeps increasing through at least the first five weeks of treatment.<sup id="cite_ref-pmid15886723_19-0" class="reference"><a href="#cite_note-pmid15886723-19" title=""><span>[</span>20<span>]</span></a></sup> That means that the full benefits of the current dose a patient receives are not realized for at least a month since its initiation. For example, in one 6-week study, the median time to achieving consistent response was 29 days.<sup id="cite_ref-pmid11199945_17-1" class="reference"><a href="#cite_note-pmid11199945-17" title=""><span>[</span>18<span>]</span></a></sup> Likewise, complete excretion of the drug may take several weeks. During the first week after the treatment discontinuation, the brain concentration of fluoxetine decreases only by 50%,<sup id="cite_ref-pmid15886723_19-1" class="reference"><a href="#cite_note-pmid15886723-19" title=""><span>[</span>20<span>]</span></a></sup> The blood level of norfluoxetine 4 weeks after the treatment discontinuation is about 80% of the level registered by the end of the first treatment week, and 7 weeks after the discontinuation norfluoxetine is still detectable in the blood.<sup id="cite_ref-pmid10917403_10-3" class="reference"><a href="#cite_note-pmid10917403-10" title=""><span>[</span>11<span>]</span></a></sup>A PET study compared the action of a single dose of fluoxetine on exclusively heterosexual and exclusively <a href="/wiki/Homosexuality" title="Homosexuality">homosexual</a> men who attested that their past and present <a href="/wiki/Human_sexual_behavior" title="Human sexual behavior">sexual behavior</a>, desires, and fantasies were directed entirely toward women or men, respectively. The study found that in some areas of the brain the metabolic response in these two groups was different. "Both groups, however, did exhibit similar widespread lateralized metabolic responses to fluoxetine (relative to placebo), with most areas of the brain responding in the same direction." They "did not differ on behavioral measures or blood levels of fluoxetine".<sup id="cite_ref-pmid15451388_20-0" class="reference"><a href="#cite_note-pmid15451388-20" title=""><span>[</span>21<span>]</span></a></sup></p>
<p><a name="Adverse_effects" id="Adverse_effects"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Fluoxetine&amp;action=edit&amp;section=4" title="Edit section: Adverse effects">edit</a>]</span> <span class="mw-headline">Adverse effects</span></h2>
<div class="thumb tleft">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Fluoxetine_20mg_with_Packet.jpg" class="image" title="Fluoxetine capsules (20&#160;mg), as prescribed in the United Kingdom"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Fluoxetine_20mg_with_Packet.jpg/180px-Fluoxetine_20mg_with_Packet.jpg" width="180" height="212" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Fluoxetine_20mg_with_Packet.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Fluoxetine capsules (20&#160;mg), as prescribed in the <a href="/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a></div>
</div>
</div>
<p>According to the manufacturer of Prozac brand of fluoxetine <a href="/wiki/Eli_Lilly" title="Eli Lilly">Eli Lilly</a>, fluoxetine is <a href="/wiki/Contraindicated" title="Contraindicated" class="mw-redirect">contraindicated</a> in individuals taking <a href="/wiki/Monoamine_oxidase_inhibitor" title="Monoamine oxidase inhibitor">monoamine oxidase inhibitors</a>, <a href="/wiki/Pimozide" title="Pimozide">pimozide</a> (Orap) or <a href="/wiki/Thioridazine" title="Thioridazine">thioridazine</a> (Mellaril).<sup id="cite_ref-prozacpi_8-4" class="reference"><a href="#cite_note-prozacpi-8" title=""><span>[</span>9<span>]</span></a></sup> The prescribing information recommends that the treatment of the patients with liver impairment "must be approached with caution". The elimination of fluoxetine and its metabolite norfluoxetine is about twice slower in these patients, resulting in the proportionate increase of exposure to the drug.<sup id="cite_ref-prozacpi_8-5" class="reference"><a href="#cite_note-prozacpi-8" title=""><span>[</span>9<span>]</span></a></sup></p>
<p>Among the common <a href="/wiki/Adverse_drug_reaction" title="Adverse drug reaction">adverse effects</a> associated with fluoxetine and listed in the prescribing information, the effects with the greatest difference from <a href="/wiki/Placebo" title="Placebo">placebo</a> are <a href="/wiki/Nausea" title="Nausea">nausea</a> (22% vs 9% for placebo), <a href="/wiki/Insomnia" title="Insomnia">insomnia</a> (19% vs 10% for placebo), <a href="/wiki/Somnolence" title="Somnolence">somnolence</a> (12% vs 5% for placebo), <a href="/wiki/Anorexia_(symptom)" title="Anorexia (symptom)">anorexia</a> (10% vs 3% for placebo), <a href="/wiki/Anxiety" title="Anxiety">anxiety</a> (12% vs 6% for placebo), nervousness (13% vs 8% for placebo), <a href="/wiki/Asthenia" title="Asthenia">asthenia</a> (11% vs 6% for placebo) and <a href="/wiki/Tremor" title="Tremor">tremor</a> (9% vs 2% for placebo). Those that most often resulted in interruption of the treatment were anxiety, insomnia, and nervousness (1-2% each), and in pediatric trials—mania (2%).<sup id="cite_ref-prozacpi_8-6" class="reference"><a href="#cite_note-prozacpi-8" title=""><span>[</span>9<span>]</span></a></sup> Similarly to other SSRIs, <a href="/wiki/Sexual_dysfunction" title="Sexual dysfunction">sexual side effects</a> are common with fluoxetine; they include <a href="/wiki/Anorgasmia" title="Anorgasmia">anorgasmia</a> and reduced <a href="/wiki/Libido" title="Libido">libido</a>.<sup id="cite_ref-cerhr-2004_21-0" class="reference"><a href="#cite_note-cerhr-2004-21" title=""><span>[</span>22<span>]</span></a></sup></p>
<p>In addition, rash or urticaria, sometimes serious, was observed in 7% patients in clinical trials; one-third of these cases resulted in discontinuation of the treatment. Postmarketing reports note several cases of complications developed in patients with rash. The symptoms included <a href="/wiki/Vasculitis" title="Vasculitis">vasculitis</a> and <a href="/wiki/Lupus_erythematosus" title="Lupus erythematosus">lupus-like syndrome</a>. Death has been reported to occur in association with these systemic events.<sup id="cite_ref-prozacpi_8-7" class="reference"><a href="#cite_note-prozacpi-8" title=""><span>[</span>9<span>]</span></a></sup></p>
<p><a href="/wiki/Akathisia" title="Akathisia">Akathisia</a>, that is inner tension, restlessness, and the inability to stay still, often accompanied by "constant pacing, purposeless movements of the feet and legs, and marked anxiety," is a common side effect of fluoxetine.<sup id="cite_ref-pmid2549018_22-0" class="reference"><a href="#cite_note-pmid2549018-22" title=""><span>[</span>23<span>]</span></a></sup><sup id="cite_ref-pmid8909330_23-0" class="reference"><a href="#cite_note-pmid8909330-23" title=""><span>[</span>24<span>]</span></a></sup> Akathisia usually begins after the initiation of the treatment or increase of the dose and disappears after fluoxetine is stopped or its dose is decreased, or after treatment with <a href="/wiki/Propranolol" title="Propranolol">propranolol</a>.<sup id="cite_ref-pmid14870959_24-0" class="reference"><a href="#cite_note-pmid14870959-24" title=""><span>[</span>25<span>]</span></a></sup><sup id="cite_ref-pmid1752848_25-0" class="reference"><a href="#cite_note-pmid1752848-25" title=""><span>[</span>26<span>]</span></a></sup><sup id="cite_ref-pmid2549018_22-1" class="reference"><a href="#cite_note-pmid2549018-22" title=""><span>[</span>23<span>]</span></a></sup> There are case reports directly linking akathisia with suicidal attempts, with patients feeling better after the withdrawal of fluoxetine, and again developing severe akathisia on repeated exposure to fluoxetine. These patients described "that the development of the akathisia made them feel suicidal and that it had precipitated their prior suicide attempts."<sup id="cite_ref-pmid1752848_25-1" class="reference"><a href="#cite_note-pmid1752848-25" title=""><span>[</span>26<span>]</span></a></sup> The experts note that because of the link of akathisia with suicide and the distress it causes to the patient, "it is of vital importance to increase awareness amongst staff and patients of the symptoms of this relatively common condition".<sup id="cite_ref-pmid12404546_26-0" class="reference"><a href="#cite_note-pmid12404546-26" title=""><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-pmid16449715_27-0" class="reference"><a href="#cite_note-pmid16449715-27" title=""><span>[</span>28<span>]</span></a></sup> More rarely, fluoxetine has been associated with related movement disorders acute <a href="/wiki/Dystonia" title="Dystonia">dystonia</a> and <a href="/wiki/Tardive_dyskinesia" title="Tardive dyskinesia">tardive dyskinesia</a>.<sup id="cite_ref-pmid8909330_23-1" class="reference"><a href="#cite_note-pmid8909330-23" title=""><span>[</span>24<span>]</span></a></sup><sup id="cite_ref-28" class="reference"><a href="#cite_note-28" title=""><span>[</span>29<span>]</span></a></sup><sup id="cite_ref-29" class="reference"><a href="#cite_note-29" title=""><span>[</span>30<span>]</span></a></sup></p>
<p>Fluoxetine taken during pregnancy also increases rate of poor neonatal adaptation.<sup id="cite_ref-cerhr-2004_21-1" class="reference"><a href="#cite_note-cerhr-2004-21" title=""><span>[</span>22<span>]</span></a></sup> Because fluoxetine is excreted in <a href="/wiki/Breast_milk" title="Breast milk">human milk</a>, nursing while on fluoxetine is not recommended.<sup id="cite_ref-insert_30-0" class="reference"><a href="#cite_note-insert-30" title=""><span>[</span>31<span>]</span></a></sup> The American Association of Pediatrics classifies fluoxetine as a drug for which the effect on the nursing infant is unknown but may be of concern.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31" title=""><span>[</span>32<span>]</span></a></sup></p>
<p><a name="Discontinuation_syndrome" id="Discontinuation_syndrome"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Fluoxetine&amp;action=edit&amp;section=5" title="Edit section: Discontinuation syndrome">edit</a>]</span> <span class="mw-headline">Discontinuation syndrome</span></h3>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/SSRI_discontinuation_syndrome" title="SSRI discontinuation syndrome">SSRI discontinuation syndrome</a></div>
<p>Several case reports in the literature describe severe withdrawal or discontinuation symptoms following an abrupt interruption of fluoxetine treatment.<sup id="cite_ref-pmid17913343_32-0" class="reference"><a href="#cite_note-pmid17913343-32" title=""><span>[</span>33<span>]</span></a></sup> It is generally believed that the side effects of the fluoxetine discontinuation are mild,<sup id="cite_ref-pmid17913343_32-1" class="reference"><a href="#cite_note-pmid17913343-32" title=""><span>[</span>33<span>]</span></a></sup> and one of the recommended strategies for the management of discontinuation syndrome with other SSRIs is to substitute fluoxetine for the original agent, in cases where tapering off the dose of the original SSRI is ineffective.<sup id="cite_ref-pmid9219493_33-0" class="reference"><a href="#cite_note-pmid9219493-33" title=""><span>[</span>34<span>]</span></a></sup><sup id="cite_ref-pmid16683860_34-0" class="reference"><a href="#cite_note-pmid16683860-34" title=""><span>[</span>35<span>]</span></a></sup> The <a href="/wiki/Double-blind" title="Double-blind" class="mw-redirect">double-blind</a> controlled studies support this opinion. No increase in side effects was observed in several studies when the treatment with fluoxetine was blindly interrupted for a short time (4-8 days) and then re-instated, this result being consistent with its slow elimination from the body. More side effects occurred during the interruption of <a href="/wiki/Sertraline" title="Sertraline">sertraline</a> (Zoloft) in these studies, and significantly more—during the interruption of paroxetine.<sup id="cite_ref-pmid16683858_35-0" class="reference"><a href="#cite_note-pmid16683858-35" title=""><span>[</span>36<span>]</span></a></sup> In a longer, 6 week-long, blind discontinuation study, insignificantly higher (32% vs 27%) overall rate of new or worsened side effects was observed in the group that discontinued fluoxetine than in the group that continued treatment. However, significantly higher 4% rate of somnolence at week 2 and 5-7% rate of dizziness at weeks 4-6 were reported by the patients in the discontinuation group. This prolonged course of the discontinuation symptoms, with dizziness persisting to the end of the study, is also consistent with the long half-life of fluoxetine in the body.<sup id="cite_ref-pmid9617977_36-0" class="reference"><a href="#cite_note-pmid9617977-36" title=""><span>[</span>37<span>]</span></a></sup></p>
<p><a name="Suicidality_in_antidepressant_trials" id="Suicidality_in_antidepressant_trials"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Fluoxetine&amp;action=edit&amp;section=6" title="Edit section: Suicidality in antidepressant trials">edit</a>]</span> <span class="mw-headline">Suicidality in antidepressant trials</span></h3>
<p>The FDA requires all antidepressants, including fluoxetine, to carry a <a href="/wiki/Black_box_warning" title="Black box warning">black box warning</a> stating that antidepressants may increase the risk of suicide in persons younger than 25. This warning is based on statistical analyses conducted by two independent groups of the FDA experts that found a 2-fold increase of the suicidal ideation and behavior in children and adolescents, and 1.5-fold increase of suicidality in the 18–24 age group. The suicidality was slightly decreased for those older than 24, and statistically significantly lower in the 65 and older group.<sup id="cite_ref-FDA_37-0" class="reference"><a href="#cite_note-FDA-37" title=""><span>[</span>38<span>]</span></a></sup><sup id="cite_ref-FDA2_38-0" class="reference"><a href="#cite_note-FDA2-38" title=""><span>[</span>39<span>]</span></a></sup><sup id="cite_ref-FDA3_39-0" class="reference"><a href="#cite_note-FDA3-39" title=""><span>[</span>40<span>]</span></a></sup> This analysis was criticized by Donald Klein who noted that suicidality, that is suicidal ideation and behavior, is not necessarily a good surrogate marker for completed suicide, and it is still possible that antidepressants may prevent actual suicide while increasing suicidality.<sup id="cite_ref-pmid16395296_40-0" class="reference"><a href="#cite_note-pmid16395296-40" title=""><span>[</span>41<span>]</span></a></sup> This opinion goes against the general consensus that "suicidal ideation has been associated with <a href="/wiki/Parasuicide" title="Parasuicide" class="mw-redirect">suicide attempt</a> in retrospective studies and with suicide in prospective studies."<sup id="cite_ref-pmid18190232_41-0" class="reference"><a href="#cite_note-pmid18190232-41" title=""><span>[</span>42<span>]</span></a></sup></p>
<p><a name="Suicidality_and_fluoxetine" id="Suicidality_and_fluoxetine"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Fluoxetine&amp;action=edit&amp;section=7" title="Edit section: Suicidality and fluoxetine">edit</a>]</span> <span class="mw-headline">Suicidality and fluoxetine</span></h3>
<p><a href="/wiki/Suicidal_ideation" title="Suicidal ideation">Suicidal ideation</a> and behavior in clinical trials are rare. For the above analysis the FDA had to combine the results of 295 trials of 11 antidepressants for psychiatric indications in order to obtain <a href="/wiki/Statistically_significant" title="Statistically significant" class="mw-redirect">statistically significant</a> results. Considered separately, fluoxetine use in children increased the odds of suicidality by 50% (not statistically significant due to the low number of cases),<sup id="cite_ref-FDA4_42-0" class="reference"><a href="#cite_note-FDA4-42" title=""><span>[</span>43<span>]</span></a></sup> and in adults decreased the odds of suicidality by approximately 30% (statistically significant).<sup id="cite_ref-FDA2_38-1" class="reference"><a href="#cite_note-FDA2-38" title=""><span>[</span>39<span>]</span></a></sup><sup id="cite_ref-FDA3_39-1" class="reference"><a href="#cite_note-FDA3-39" title=""><span>[</span>40<span>]</span></a></sup> Similarly, the analysis conducted by the UK <a href="/wiki/Medicines_and_Healthcare_products_Regulatory_Agency" title="Medicines and Healthcare products Regulatory Agency">MHRA</a> found a 50% increase of odds of suicide-related events, not reaching statistical significance, in the children and adolescents on fluoxetine as compared to the ones on placebo. According to the MHRA data, for adults fluoxetine did not change the rate of <a href="/wiki/Self-harm" title="Self-harm" class="mw-redirect">self-harm</a> and statistically significantly decreased suicidal ideation by 50%.<sup id="cite_ref-43" class="reference"><a href="#cite_note-43" title=""><span>[</span>44<span>]</span></a></sup><sup id="cite_ref-pmid15718537_44-0" class="reference"><a href="#cite_note-pmid15718537-44" title=""><span>[</span>45<span>]</span></a></sup></p>
<p><a name="Interactions" id="Interactions"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Fluoxetine&amp;action=edit&amp;section=8" title="Edit section: Interactions">edit</a>]</span> <span class="mw-headline">Interactions</span></h2>
<p>Fluoxetine and norfluoxetine <a href="/wiki/Enzyme_inhibitor" title="Enzyme inhibitor">inhibit</a> many <a href="/wiki/Isozyme" title="Isozyme">isozymes</a> of the <a href="/wiki/Cytochrome_P450" title="Cytochrome P450">cytochrome P450</a> system that make <a href="/wiki/Drug_metabolism" title="Drug metabolism">drug metabolism</a> possible. Both are potent inhibitors of <a href="/wiki/CYP2D6" title="CYP2D6">CYP2D6</a> (the main enzyme responsible for their metabolism) and mild to moderate inhibitors of <a href="/wiki/CYP1A2" title="CYP1A2">CYP1A2</a>, <a href="/wiki/CYP2B6" title="CYP2B6">CYP2B6</a>, <a href="/wiki/CYP2C9" title="CYP2C9">CYP2C9</a>/<a href="/wiki/CYP2C19" title="CYP2C19">2C19</a>, and <a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a>; furthermore, they inhibit the activity of <a href="/wiki/P-glycoprotein" title="P-glycoprotein">P-glycoprotein</a>, a type of <a href="/wiki/Membrane_transport_protein" title="Membrane transport protein">membrane transport protein</a> that plays an important role in drug transport and metabolism.<sup id="cite_ref-Sandson_45-0" class="reference"><a href="#cite_note-Sandson-45" title=""><span>[</span>46<span>]</span></a></sup> This extensive effect on the body's pathways for drug metabolism creates the potential for <a href="/wiki/Drug_interaction" title="Drug interaction">interactions</a> with many commonly used drugs.<sup id="cite_ref-Sandson_45-1" class="reference"><a href="#cite_note-Sandson-45" title=""><span>[</span>46<span>]</span></a></sup><sup id="cite_ref-46" class="reference"><a href="#cite_note-46" title=""><span>[</span>47<span>]</span></a></sup></p>
<p>The simultaneous use of fluoxetine with <a href="/wiki/Triptans" title="Triptans" class="mw-redirect">triptans</a>, <a href="/wiki/Tramadol" title="Tramadol">tramadol</a> or other <a href="/wiki/Serotonergic" title="Serotonergic">serotonergic</a> agents can result in a rare, but potentially life-threatening adverse drug reaction called <a href="/wiki/Serotonin_syndrome" title="Serotonin syndrome">serotonin syndrome</a>.</p>
<p><a name="Controversy" id="Controversy"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Fluoxetine&amp;action=edit&amp;section=9" title="Edit section: Controversy">edit</a>]</span> <span class="mw-headline">Controversy</span></h2>
<p>"In 1989, <a href="/wiki/Standard_Gravure_shooting" title="Standard Gravure shooting">Joseph Wesbecker</a> shot dead eight people and injured 12 others before killing himself at his place of work in Kentucky. Wesbecker had been taking the selective serotonin reuptake inhibitor (SSRI) antidepressant fluoxetine for four weeks before these homicides, and this led to a legal action against the makers of fluoxetine, Eli Lilly.<sup id="cite_ref-47" class="reference"><a href="#cite_note-47" title=""><span>[</span>48<span>]</span></a></sup> The case was tried and settled in 1994, and as part of the settlement a number of pharmaceutical company documents about drug-induced activation were released into the public domain. Subsequent legal cases...have further raised the possibility of a link between antidepressant use and violence."<sup id="cite_ref-48" class="reference"><a href="#cite_note-48" title=""><span>[</span>49<span>]</span></a></sup></p>
<p>A <a href="/wiki/Meta-analysis" title="Meta-analysis">meta-analysis</a> published in February 2008 combined 35 clinical trials of four newer antidepressants (fluoxetine, <a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a> (Paxil), <a href="/wiki/Nefazodone" title="Nefazodone">nefazodone</a> (Serzone) and <a href="/wiki/Venlafaxine" title="Venlafaxine">venlafaxine</a> (Effexor)). These antidepressants belonging to three different pharmacological groups were considered together, and the authors did not analyze them separately. The authors concluded that "although the difference [between the placebo and antidepressants] easily attained <a href="/wiki/Statistical_significance" title="Statistical significance">statistical significance</a>", it did not meet the criterion for clinical significance, as used by <a href="/wiki/National_Institute_for_Health_and_Clinical_Excellence" title="National Institute for Health and Clinical Excellence">National Institute for Health and Clinical Excellence</a> (UK), "for any but the most severely depressed patients."<sup id="cite_ref-49" class="reference"><a href="#cite_note-49" title=""><span>[</span>50<span>]</span></a></sup> Some articles in the press using the titles "The creation of the Prozac myth"<sup id="cite_ref-50" class="reference"><a href="#cite_note-50" title=""><span>[</span>51<span>]</span></a></sup> and "Prozac does not work in majority of depressed patients"<sup id="cite_ref-51" class="reference"><a href="#cite_note-51" title=""><span>[</span>52<span>]</span></a></sup><sup id="cite_ref-52" class="reference"><a href="#cite_note-52" title=""><span>[</span>53<span>]</span></a></sup> presented these general findings about the relative efficacy of antidepressants and placebo as the findings about ineffectiveness of fluoxetine. In a follow-up article, the authors of the meta-analysis noted that "unfortunately, during its initial coverage, the media often portrayed the results as “antidepressants do not work”, which misrepresented our more nuanced pattern of findings."<sup id="cite_ref-53" class="reference"><a href="#cite_note-53" title=""><span>[</span>54<span>]</span></a></sup></p>
<p><a name="Prozac_in_popular_culture" id="Prozac_in_popular_culture"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Fluoxetine&amp;action=edit&amp;section=10" title="Edit section: Prozac in popular culture">edit</a>]</span> <span class="mw-headline">Prozac in popular culture</span></h2>
<p>Because of its wide appeal as a popular anti-depressant, Prozac has had numerous references to it in popular culture, including many books, movies, and songs. For example, the autobiographical book <i><a href="/wiki/Prozac_Nation_(book)" title="Prozac Nation (book)">Prozac Nation</a></i> was written in 1994 by <a href="/wiki/Elizabeth_Wurtzel" title="Elizabeth Wurtzel">Elizabeth Wurtzel</a>; it was turned into a movie of the same name, <i><a href="/wiki/Prozac_Nation_(film)" title="Prozac Nation (film)">Prozac Nation</a></i>, in 2001, starring <a href="/wiki/Christina_Ricci" title="Christina Ricci">Christina Ricci</a>. <a href="/wiki/Jill_Sobule" title="Jill Sobule">Jill Sobule</a> and <a href="/w/index.php?title=Elise_Thoron&amp;action=edit&amp;redlink=1" class="new" title="Elise Thoron (page does not exist)">Elise Thoron</a> wrote the musical <i>Prozak and the Platypus</i> which opened off-Broadway in 2005.</p>
<p>At least three contemporary music groups have derived their name from Prozac, including the punk rock band <a href="/wiki/Prozac%2B" title="Prozac+">Prozac+</a>, the rapper <a href="/wiki/Prozak_(rapper)" title="Prozak (rapper)">Prozak</a> and the pop band <a href="/wiki/Prozz%C3%A4k" title="Prozzäk">Prozzäk</a>. Including Wmass Pop-Punk Band "The Prozaks"</p>
<p>In common vernacular, "Prozac" may not always refer to fluoxetine itself, but rather more generically to any anti-depressent drug.</p>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Fluoxetine&amp;action=edit&amp;section=11" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small">
<ol class="references">
<li id="cite_note-RxList-0">^ <a href="#cite_ref-RxList_0-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-RxList_0-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-RxList_0-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="web"><a href="http://www.rxlist.com/cgi/generic/fluoxetine_cp.htm" class="external text" title="http://www.rxlist.com/cgi/generic/fluoxetine_cp.htm" rel="nofollow">"Prozac Pharmacology, Pharmacokinetics,Studies, Metabolism"</a>. RxList.com. 2007<span class="printonly">. <a href="http://www.rxlist.com/cgi/generic/fluoxetine_cp.htm" class="external free" title="http://www.rxlist.com/cgi/generic/fluoxetine_cp.htm" rel="nofollow">http://www.rxlist.com/cgi/generic/fluoxetine_cp.htm</a></span><span class="reference-accessdate">. Retrieved on 2007-04-14</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Prozac+Pharmacology%2C+Pharmacokinetics%2CStudies%2C+Metabolism&amp;rft.atitle=&amp;rft.date=2007&amp;rft.pub=RxList.com&amp;rft_id=http%3A%2F%2Fwww.rxlist.com%2Fcgi%2Fgeneric%2Ffluoxetine_cp.htm&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-1"><b><a href="#cite_ref-1" title="">^</a></b> After <a href="/wiki/Sertraline" title="Sertraline">sertraline</a> and <a href="/wiki/Escitalopram" title="Escitalopram">escitalopram</a>, see: <cite style="font-style:normal" class="web"><a href="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491181" class="external text" title="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491181" rel="nofollow">"Top 200 Generic Drugs by Units in 2007"</a><span class="printonly">. <a href="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491181" class="external free" title="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491181" rel="nofollow">http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491181</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Top+200+Generic+Drugs+by+Units+in+2007&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fwww.drugtopics.com%2Fdrugtopics%2Farticle%2FarticleDetail.jsp%3Fid%3D491181&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span> and <cite style="font-style:normal" class="web" id="CITEREFVerispan2008">Verispan (2008-02-18). <a href="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491207" class="external text" title="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491207" rel="nofollow">"Top 200 Brand Drugs by Units in 2007"</a> (PDF). Drug Topics<span class="printonly">. <a href="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491207" class="external free" title="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491207" rel="nofollow">http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491207</a></span><span class="reference-accessdate">. Retrieved on 2008-03-30</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Top+200+Brand+Drugs+by+Units+in+2007&amp;rft.atitle=&amp;rft.aulast=Verispan&amp;rft.au=Verispan&amp;rft.date=2008-02-18&amp;rft.pub=Drug+Topics&amp;rft_id=http%3A%2F%2Fwww.drugtopics.com%2Fdrugtopics%2Farticle%2FarticleDetail.jsp%3Fid%3D491207&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Wong-2">^ <a href="#cite_ref-Wong_2-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Wong_2-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Wong_2-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Wong_2-3" title=""><sup><i><b>d</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFWong.2C_DT.2C_Bymaster_FP.2C_Engleman_EA1995">Wong, DT, Bymaster FP, Engleman EA (1995). "Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication". <i>Life Sci</i> <b>57</b> (5): 411–41. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2F0024-3205%2895%2900209-O" class="external text" title="http://dx.doi.org/10.1016%2F0024-3205%2895%2900209-O" rel="nofollow">10.1016/0024-3205(95)00209-O</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7623609" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/7623609">PMID 7623609</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Prozac+%28fluoxetine%2C+Lilly+110140%29%2C+the+first+selective+serotonin+uptake+inhibitor+and+an+antidepressant+drug%3A+twenty+years+since+its+first+publication&amp;rft.jtitle=Life+Sci&amp;rft.aulast=Wong%2C+DT%2C+Bymaster+FP%2C+Engleman+EA&amp;rft.au=Wong%2C+DT%2C+Bymaster+FP%2C+Engleman+EA&amp;rft.date=1995&amp;rft.volume=57&amp;rft.issue=5&amp;rft.pages=411%E2%80%9341&amp;rft_id=info:doi/10.1016%2F0024-3205%2895%2900209-O&amp;rft_id=info:pmid/7623609&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-3"><b><a href="#cite_ref-3" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWong_D.2C_Horng_J.2C_Bymaster_F.2C_Hauser_K.2C_Molloy_B1974">Wong D, Horng J, Bymaster F, Hauser K, Molloy B (1974). "A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine". <i>Life Sci</i> <b>15</b> (3): 471–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2F0024-3205%2874%2990345-2" class="external text" title="http://dx.doi.org/10.1016%2F0024-3205%2874%2990345-2" rel="nofollow">10.1016/0024-3205(74)90345-2</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/4549929" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/4549929">PMID 4549929</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+selective+inhibitor+of+serotonin+uptake%3A+Lilly+110140%2C+3-%28p-trifluoromethylphenoxy%29-N-methyl-3-phenylpropylamine&amp;rft.jtitle=Life+Sci&amp;rft.aulast=Wong+D%2C+Horng+J%2C+Bymaster+F%2C+Hauser+K%2C+Molloy+B&amp;rft.au=Wong+D%2C+Horng+J%2C+Bymaster+F%2C+Hauser+K%2C+Molloy+B&amp;rft.date=1974&amp;rft.volume=15&amp;rft.issue=3&amp;rft.pages=471%E2%80%939&amp;rft_id=info:doi/10.1016%2F0024-3205%2874%2990345-2&amp;rft_id=info:pmid/4549929&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-4"><b><a href="#cite_ref-4" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCarlsson_A.2C_Wong_DT1997">Carlsson A, Wong DT (1997). "A note on the discovery of selective serotonin reuptake inhibitors". <i>Life Sci</i> <b>61</b> (12): 1203. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0024-3205%2897%2900662-0" class="external text" title="http://dx.doi.org/10.1016%2FS0024-3205%2897%2900662-0" rel="nofollow">10.1016/S0024-3205(97)00662-0</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9315511" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9315511">PMID 9315511</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+note+on+the+discovery+of+selective+serotonin+reuptake+inhibitors&amp;rft.jtitle=Life+Sci&amp;rft.aulast=Carlsson+A%2C+Wong+DT&amp;rft.au=Carlsson+A%2C+Wong+DT&amp;rft.date=1997&amp;rft.volume=61&amp;rft.issue=12&amp;rft.pages=1203&amp;rft_id=info:doi/10.1016%2FS0024-3205%2897%2900662-0&amp;rft_id=info:pmid/9315511&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-5"><b><a href="#cite_ref-5" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSwiatek2001">Swiatek, Jeff (August 2, 2001), "<a href="http://www2.indystar.com/library/factfiles/business/companies/lilly/stories/2001_0802.html" class="external text" title="http://www2.indystar.com/library/factfiles/business/companies/lilly/stories/2001_0802.html" rel="nofollow">Prozac's profitable run coming to an end for Lilly</a>", <i>The Indianapolis Star</i><span class="printonly">, <a href="http://www2.indystar.com/library/factfiles/business/companies/lilly/stories/2001_0802.html" class="external free" title="http://www2.indystar.com/library/factfiles/business/companies/lilly/stories/2001_0802.html" rel="nofollow">http://www2.indystar.com/library/factfiles/business/companies/lilly/stories/2001_0802.html</a></span></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Prozac%27s+profitable+run+coming+to+an+end+for+Lilly&amp;rft.jtitle=The+Indianapolis+Star&amp;rft.aulast=Swiatek&amp;rft.aufirst=Jeff&amp;rft.au=Swiatek%2C+Jeff&amp;rft.date=August+2%2C+2001&amp;rft_id=http%3A%2F%2Fwww2.indystar.com%2Flibrary%2Ffactfiles%2Fbusiness%2Fcompanies%2Flilly%2Fstories%2F2001_0802.html&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-6"><b><a href="#cite_ref-6" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=018936&amp;TABLE1=OB_Rx" class="external text" title="http://www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=018936&amp;TABLE1=OB_Rx" rel="nofollow">"Electronic Orange Book"</a>. Food and Drug Administration. April 2007<span class="printonly">. <a href="http://www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=018936&amp;TABLE1=OB_Rx" class="external free" title="http://www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=018936&amp;TABLE1=OB_Rx" rel="nofollow">http://www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=018936&amp;TABLE1=OB_Rx</a></span><span class="reference-accessdate">. Retrieved on May 24 2007</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Electronic+Orange+Book&amp;rft.atitle=&amp;rft.date=April+2007&amp;rft.pub=Food+and+Drug+Administration&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fscripts%2Fcder%2Fob%2Fdocs%2Fobdetail.cfm%3FAppl_No%3D018936%26TABLE1%3DOB_Rx&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-7"><b><a href="#cite_ref-7" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.express-scripts.com/pharmacist/notifications/docs/genericdrugs.htm" class="external text" title="http://www.express-scripts.com/pharmacist/notifications/docs/genericdrugs.htm" rel="nofollow">"Patent Expiration Dates for Common Brand-Name Drugs"</a><span class="printonly">. <a href="http://www.express-scripts.com/pharmacist/notifications/docs/genericdrugs.htm" class="external free" title="http://www.express-scripts.com/pharmacist/notifications/docs/genericdrugs.htm" rel="nofollow">http://www.express-scripts.com/pharmacist/notifications/docs/genericdrugs.htm</a></span><span class="reference-accessdate">. Retrieved on 2007-07-20</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Patent+Expiration+Dates+for+Common+Brand-Name+Drugs&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fwww.express-scripts.com%2Fpharmacist%2Fnotifications%2Fdocs%2Fgenericdrugs.htm&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-prozacpi-8">^ <a href="#cite_ref-prozacpi_8-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-prozacpi_8-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-prozacpi_8-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-prozacpi_8-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-prozacpi_8-4" title=""><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-prozacpi_8-5" title=""><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-prozacpi_8-6" title=""><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-prozacpi_8-7" title=""><sup><i><b>h</b></i></sup></a> <cite style="font-style:normal" class="web"><a href="http://pi.lilly.com/us/prozac.pdf" class="external text" title="http://pi.lilly.com/us/prozac.pdf" rel="nofollow">"Prozac prescribing information"</a> (PDF). Eli Lilly. 2007-06-21<span class="printonly">. <a href="http://pi.lilly.com/us/prozac.pdf" class="external free" title="http://pi.lilly.com/us/prozac.pdf" rel="nofollow">http://pi.lilly.com/us/prozac.pdf</a></span><span class="reference-accessdate">. Retrieved on 2008-01-09</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Prozac+prescribing+information&amp;rft.atitle=&amp;rft.date=2007-06-21&amp;rft.pub=Eli+Lilly&amp;rft_id=http%3A%2F%2Fpi.lilly.com%2Fus%2Fprozac.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid8927671-9"><b><a href="#cite_ref-pmid8927671_9-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBurke_WJ.2C_Hendricks_SE.2C_McArthur-Campbell_D.2C_Jacques_D.2C_Stull_T1996">Burke WJ, Hendricks SE, McArthur-Campbell D, Jacques D, Stull T (1996). "Fluoxetine and norfluoxetine serum concentrations and clinical response in weekly versus daily dosing". <i>Psychopharmacol Bull</i> <b>32</b> (1): 27–32. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8927671" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8927671">PMID 8927671</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Fluoxetine+and+norfluoxetine+serum+concentrations+and+clinical+response+in+weekly+versus+daily+dosing&amp;rft.jtitle=Psychopharmacol+Bull&amp;rft.aulast=Burke+WJ%2C+Hendricks+SE%2C+McArthur-Campbell+D%2C+Jacques+D%2C+Stull+T&amp;rft.au=Burke+WJ%2C+Hendricks+SE%2C+McArthur-Campbell+D%2C+Jacques+D%2C+Stull+T&amp;rft.date=1996&amp;rft.volume=32&amp;rft.issue=1&amp;rft.pages=27%E2%80%9332&amp;rft_id=info:pmid/8927671&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10917403-10">^ <a href="#cite_ref-pmid10917403_10-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid10917403_10-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid10917403_10-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid10917403_10-3" title=""><sup><i><b>d</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFBurke_WJ.2C_Hendricks_SE.2C_McArthur-Miller_D.2C_Jacques_D.2C_Bessette_D.2C_McKillup_T.2C_Stull_T.2C_Wilson_J2000">Burke WJ, Hendricks SE, McArthur-Miller D, Jacques D, Bessette D, McKillup T, Stull T, Wilson J (2000). "Weekly dosing of fluoxetine for the continuation phase of treatment of major depression: results of a placebo-controlled, randomized clinical trial". <i>J Clin Psychopharmacol</i> <b>20</b> (4): 423–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10917403" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10917403">PMID 10917403</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Weekly+dosing+of+fluoxetine+for+the+continuation+phase+of+treatment+of+major+depression%3A+results+of+a+placebo-controlled%2C+randomized+clinical+trial&amp;rft.jtitle=J+Clin+Psychopharmacol&amp;rft.aulast=Burke+WJ%2C+Hendricks+SE%2C+McArthur-Miller+D%2C+Jacques+D%2C+Bessette+D%2C+McKillup+T%2C+Stull+T%2C+Wilson+J&amp;rft.au=Burke+WJ%2C+Hendricks+SE%2C+McArthur-Miller+D%2C+Jacques+D%2C+Bessette+D%2C+McKillup+T%2C+Stull+T%2C+Wilson+J&amp;rft.date=2000&amp;rft.volume=20&amp;rft.issue=4&amp;rft.pages=423%E2%80%937&amp;rft_id=info:pmid/10917403&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid7935707-11">^ <a href="#cite_ref-pmid7935707_11-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid7935707_11-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFGram_L1994">Gram L (1994). "Fluoxetine". <i>N. Engl. J. Med.</i> <b>331</b> (20): 1354–61. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7935707" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/7935707">PMID 7935707</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Fluoxetine&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Gram+L&amp;rft.au=Gram+L&amp;rft.date=1994&amp;rft.volume=331&amp;rft.issue=20&amp;rft.pages=1354%E2%80%9361&amp;rft_id=info:pmid/7935707&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18215618-12"><b><a href="#cite_ref-pmid18215618_12-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFUhr_M.2C_Tontsch_A.2C_Namendorf_C.2C_Ripke_S.2C_Lucae_S.2C_Ising_M.2C_Dose_T.2C_Ebinger_M.2C_Rosenhagen_M.2C_Kohli_M.2C_Kloiber_S.2C_Salyakina_D.2C_Bettecken_T.2C_Specht_M.2C_P.C3.BCtz_B.2C_Binder_EB.2C_M.C3.BCller-Myhsok_B.2C_Holsboer_F2008">Uhr M, Tontsch A, Namendorf C, Ripke S, Lucae S, Ising M, Dose T, Ebinger M, Rosenhagen M, Kohli M, Kloiber S, Salyakina D, Bettecken T, Specht M, Pütz B, Binder EB, Müller-Myhsok B, Holsboer F (2008). "Polymorphisms in the Drug Transporter Gene ABCB1 Predict Antidepressant Treatment Response in Depression". <i>Neuron</i> <b>57</b> (2): 203–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.neuron.2007.11.017" class="external text" title="http://dx.doi.org/10.1016%2Fj.neuron.2007.11.017" rel="nofollow">10.1016/j.neuron.2007.11.017</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18215618" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18215618">PMID 18215618</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Polymorphisms+in+the+Drug+Transporter+Gene+ABCB1+Predict+Antidepressant+Treatment+Response+in+Depression&amp;rft.jtitle=Neuron&amp;rft.aulast=Uhr+M%2C+Tontsch+A%2C+Namendorf+C%2C+Ripke+S%2C+Lucae+S%2C+Ising+M%2C+Dose+T%2C+Ebinger+M%2C+Rosenhagen+M%2C+Kohli+M%2C+Kloiber+S%2C+Salyakina+D%2C+Bettecken+T%2C+Specht+M%2C+P%C3%BCtz+B%2C+Binder+EB%2C+M%C3%BCller-Myhsok+B%2C+Holsboer+F&amp;rft.au=Uhr+M%2C+Tontsch+A%2C+Namendorf+C%2C+Ripke+S%2C+Lucae+S%2C+Ising+M%2C+Dose+T%2C+Ebinger+M%2C+Rosenhagen+M%2C+Kohli+M%2C+Kloiber+S%2C+Salyakina+D%2C+Bettecken+T%2C+Specht+M%2C+P%C3%BCtz+B%2C+Binder+EB%2C+M%C3%BCller-Myhsok+B%2C+Holsboer+F&amp;rft.date=2008&amp;rft.volume=57&amp;rft.issue=2&amp;rft.pages=203%E2%80%939&amp;rft_id=info:doi/10.1016%2Fj.neuron.2007.11.017&amp;rft_id=info:pmid/18215618&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17913323-13"><b><a href="#cite_ref-pmid17913323_13-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKato_M.2C_Fukuda_T.2C_Serretti_A.2C_Wakeno_M.2C_Okugawa_G.2C_Ikenaga_Y.2C_Hosoi_Y.2C_Takekita_Y.2C_Mandelli_L.2C_Azuma_J.2C_Kinoshita_T2008">Kato M, Fukuda T, Serretti A, Wakeno M, Okugawa G, Ikenaga Y, Hosoi Y, Takekita Y, Mandelli L, Azuma J, Kinoshita T (2008). "ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder". <i>Prog. Neuropsychopharmacol. Biol. Psychiatry</i> <b>32</b> (2): 398–404. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.pnpbp.2007.09.003" class="external text" title="http://dx.doi.org/10.1016%2Fj.pnpbp.2007.09.003" rel="nofollow">10.1016/j.pnpbp.2007.09.003</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17913323" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17913323">PMID 17913323</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=ABCB1+%28MDR1%29+gene+polymorphisms+are+associated+with+the+clinical+response+to+paroxetine+in+patients+with+major+depressive+disorder&amp;rft.jtitle=Prog.+Neuropsychopharmacol.+Biol.+Psychiatry&amp;rft.aulast=Kato+M%2C+Fukuda+T%2C+Serretti+A%2C+Wakeno+M%2C+Okugawa+G%2C+Ikenaga+Y%2C+Hosoi+Y%2C+Takekita+Y%2C+Mandelli+L%2C+Azuma+J%2C+Kinoshita+T&amp;rft.au=Kato+M%2C+Fukuda+T%2C+Serretti+A%2C+Wakeno+M%2C+Okugawa+G%2C+Ikenaga+Y%2C+Hosoi+Y%2C+Takekita+Y%2C+Mandelli+L%2C+Azuma+J%2C+Kinoshita+T&amp;rft.date=2008&amp;rft.volume=32&amp;rft.issue=2&amp;rft.pages=398%E2%80%93404&amp;rft_id=info:doi/10.1016%2Fj.pnpbp.2007.09.003&amp;rft_id=info:pmid/17913323&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-14"><b><a href="#cite_ref-14" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMandrioli_R.2C_Forti_GC.2C_Raggi_MA2006">Mandrioli R, Forti GC, Raggi MA (February 2006). "<a href="http://www.bentham-direct.org/pages/content.php?CDM/2006/00000007/00000002/0002F.SGM" class="external text" title="http://www.bentham-direct.org/pages/content.php?CDM/2006/00000007/00000002/0002F.SGM" rel="nofollow">Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450</a>". <i>Current Drug Metabolism</i> <b>7</b> (2): 127–33. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16472103" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16472103">PMID 16472103</a><span class="printonly">. <a href="http://www.bentham-direct.org/pages/content.php?CDM/2006/00000007/00000002/0002F.SGM" class="external free" title="http://www.bentham-direct.org/pages/content.php?CDM/2006/00000007/00000002/0002F.SGM" rel="nofollow">http://www.bentham-direct.org/pages/content.php?CDM/2006/00000007/00000002/0002F.SGM</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Fluoxetine+metabolism+and+pharmacological+interactions%3A+the+role+of+cytochrome+p450&amp;rft.jtitle=Current+Drug+Metabolism&amp;rft.aulast=Mandrioli+R%2C+Forti+GC%2C+Raggi+MA&amp;rft.au=Mandrioli+R%2C+Forti+GC%2C+Raggi+MA&amp;rft.date=February+2006&amp;rft.volume=7&amp;rft.issue=2&amp;rft.pages=127%E2%80%9333&amp;rft_id=info:pmid/16472103&amp;rft_id=http%3A%2F%2Fwww.bentham-direct.org%2Fpages%2Fcontent.php%3FCDM%2F2006%2F00000007%2F00000002%2F0002F.SGM&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-15"><b><a href="#cite_ref-15" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHiemke_C.2C_H.C3.A4rtter_S2000">Hiemke C, Härtter S (January 2000). "<a href="http://linkinghub.elsevier.com/retrieve/pii/S0163-7258(99)00048-0" class="external text" title="http://linkinghub.elsevier.com/retrieve/pii/S0163-7258(99)00048-0" rel="nofollow">Pharmacokinetics of selective serotonin reuptake inhibitors</a>". <i>Pharmacology &amp; Therapeutics</i> <b>85</b> (1): 11–28. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10674711" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10674711">PMID 10674711</a><span class="printonly">. <a href="http://linkinghub.elsevier.com/retrieve/pii/S0163-7258(99)00048-0" class="external free" title="http://linkinghub.elsevier.com/retrieve/pii/S0163-7258(99)00048-0" rel="nofollow">http://linkinghub.elsevier.com/retrieve/pii/S0163-7258(99)00048-0</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pharmacokinetics+of+selective+serotonin+reuptake+inhibitors&amp;rft.jtitle=Pharmacology+%26+Therapeutics&amp;rft.aulast=Hiemke+C%2C+H%C3%A4rtter+S&amp;rft.au=Hiemke+C%2C+H%C3%A4rtter+S&amp;rft.date=January+2000&amp;rft.volume=85&amp;rft.issue=1&amp;rft.pages=11%E2%80%9328&amp;rft_id=info:pmid/10674711&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0163-7258%2899%2900048-0&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Newcastle-16"><b><a href="#cite_ref-Newcastle_16-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.ncl.ac.uk/nnp/teaching/management/drugrx/antdep.html" class="external text" title="http://www.ncl.ac.uk/nnp/teaching/management/drugrx/antdep.html" rel="nofollow">"Drug Treatments in Psychiatry: Antidepressants"</a>. <a href="/wiki/Newcastle_University" title="Newcastle University">Newcastle University</a> School of Neurology, Neurobiology and Psychiatry. 2005<span class="printonly">. <a href="http://www.ncl.ac.uk/nnp/teaching/management/drugrx/antdep.html" class="external free" title="http://www.ncl.ac.uk/nnp/teaching/management/drugrx/antdep.html" rel="nofollow">http://www.ncl.ac.uk/nnp/teaching/management/drugrx/antdep.html</a></span><span class="reference-accessdate">. Retrieved on 2007-04-14</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Drug+Treatments+in+Psychiatry%3A+Antidepressants&amp;rft.atitle=&amp;rft.date=2005&amp;rft.pub=%5B%5BNewcastle+University%5D%5D+School+of+Neurology%2C+Neurobiology+and+Psychiatry&amp;rft_id=http%3A%2F%2Fwww.ncl.ac.uk%2Fnnp%2Fteaching%2Fmanagement%2Fdrugrx%2Fantdep.html&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11199945-17">^ <a href="#cite_ref-pmid11199945_17-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11199945_17-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFP.C3.A9rez_V.2C_Puiigdemont_D.2C_Gilaberte_I.2C_Alvarez_E.2C_Artigas_F2001">Pérez V, Puiigdemont D, Gilaberte I, Alvarez E, Artigas F (2001). "Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors". <i>J Clin Psychopharmacol</i> <b>21</b> (1): 36–45. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11199945" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11199945">PMID 11199945</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Augmentation+of+fluoxetine%27s+antidepressant+action+by+pindolol%3A+analysis+of+clinical%2C+pharmacokinetic%2C+and+methodologic+factors&amp;rft.jtitle=J+Clin+Psychopharmacol&amp;rft.aulast=P%C3%A9rez+V%2C+Puiigdemont+D%2C+Gilaberte+I%2C+Alvarez+E%2C+Artigas+F&amp;rft.au=P%C3%A9rez+V%2C+Puiigdemont+D%2C+Gilaberte+I%2C+Alvarez+E%2C+Artigas+F&amp;rft.date=2001&amp;rft.volume=21&amp;rft.issue=1&amp;rft.pages=36%E2%80%9345&amp;rft_id=info:pmid/11199945&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12063152-18"><b><a href="#cite_ref-pmid12063152_18-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBrunswick_DJ.2C_Amsterdam_JD.2C_Fawcett_J.2C_Quitkin_FM.2C_Reimherr_FW.2C_Rosenbaum_JF.2C_Beasley_CM2002">Brunswick DJ, Amsterdam JD, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, Beasley CM (2002). "Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment". <i>J Affect Disord</i> <b>68</b> (2-3): 243–9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12063152" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12063152">PMID 12063152</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Fluoxetine+and+norfluoxetine+plasma+concentrations+during+relapse-prevention+treatment&amp;rft.jtitle=J+Affect+Disord&amp;rft.aulast=Brunswick+DJ%2C+Amsterdam+JD%2C+Fawcett+J%2C+Quitkin+FM%2C+Reimherr+FW%2C+Rosenbaum+JF%2C+Beasley+CM&amp;rft.au=Brunswick+DJ%2C+Amsterdam+JD%2C+Fawcett+J%2C+Quitkin+FM%2C+Reimherr+FW%2C+Rosenbaum+JF%2C+Beasley+CM&amp;rft.date=2002&amp;rft.volume=68&amp;rft.issue=2-3&amp;rft.pages=243%E2%80%939&amp;rft_id=info:pmid/12063152&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15886723-19">^ <a href="#cite_ref-pmid15886723_19-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15886723_19-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFHenry_ME.2C_Schmidt_ME.2C_Hennen_J.2C_Villafuerte_RA.2C_Butman_ML.2C_Tran_P.2C_Kerner_LT.2C_Cohen_B.2C_Renshaw_PF2005">Henry ME, Schmidt ME, Hennen J, Villafuerte RA, Butman ML, Tran P, Kerner LT, Cohen B, Renshaw PF (2005). "A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: A 19-F MRS study". <i>Neuropsychopharmacology</i> <b>30</b> (8): 1576–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2Fsj.npp.1300749" class="external text" title="http://dx.doi.org/10.1038%2Fsj.npp.1300749" rel="nofollow">10.1038/sj.npp.1300749</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15886723" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15886723">PMID 15886723</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+comparison+of+brain+and+serum+pharmacokinetics+of+R-fluoxetine+and+racemic+fluoxetine%3A+A+19-F+MRS+study&amp;rft.jtitle=Neuropsychopharmacology&amp;rft.aulast=Henry+ME%2C+Schmidt+ME%2C+Hennen+J%2C+Villafuerte+RA%2C+Butman+ML%2C+Tran+P%2C+Kerner+LT%2C+Cohen+B%2C+Renshaw+PF&amp;rft.au=Henry+ME%2C+Schmidt+ME%2C+Hennen+J%2C+Villafuerte+RA%2C+Butman+ML%2C+Tran+P%2C+Kerner+LT%2C+Cohen+B%2C+Renshaw+PF&amp;rft.date=2005&amp;rft.volume=30&amp;rft.issue=8&amp;rft.pages=1576%E2%80%9383&amp;rft_id=info:doi/10.1038%2Fsj.npp.1300749&amp;rft_id=info:pmid/15886723&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15451388-20"><b><a href="#cite_ref-pmid15451388_20-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKinnunen_LH.2C_Moltz_H.2C_Metz_J.2C_Cooper_M2004">Kinnunen LH, Moltz H, Metz J, Cooper M (2004). "Differential brain activation in exclusively homosexual and heterosexual men produced by the selective serotonin reuptake inhibitor, fluoxetine". <i>Brain Res.</i> <b>1024</b> (1-2): 251–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.brainres.2004.07.070" class="external text" title="http://dx.doi.org/10.1016%2Fj.brainres.2004.07.070" rel="nofollow">10.1016/j.brainres.2004.07.070</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15451388" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15451388">PMID 15451388</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Differential+brain+activation+in+exclusively+homosexual+and+heterosexual+men+produced+by+the+selective+serotonin+reuptake+inhibitor%2C+fluoxetine&amp;rft.jtitle=Brain+Res.&amp;rft.aulast=Kinnunen+LH%2C+Moltz+H%2C+Metz+J%2C+Cooper+M&amp;rft.au=Kinnunen+LH%2C+Moltz+H%2C+Metz+J%2C+Cooper+M&amp;rft.date=2004&amp;rft.volume=1024&amp;rft.issue=1-2&amp;rft.pages=251%E2%80%934&amp;rft_id=info:doi/10.1016%2Fj.brainres.2004.07.070&amp;rft_id=info:pmid/15451388&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-cerhr-2004-21">^ <a href="#cite_ref-cerhr-2004_21-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-cerhr-2004_21-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class=""><i><a href="http://cerhr.niehs.nih.gov/chemicals/fluoxetine/fluoxetine_final.pdf" class="external text" title="http://cerhr.niehs.nih.gov/chemicals/fluoxetine/fluoxetine_final.pdf" rel="nofollow">NTP_CERHR Expert Panel Report on Reproductive and Developmental Toxicity of fluoxetine</a></i>, Center for the Evaluation of Risks to Human Reproduction, April 2004<span class="printonly">, <a href="http://cerhr.niehs.nih.gov/chemicals/fluoxetine/fluoxetine_final.pdf" class="external free" title="http://cerhr.niehs.nih.gov/chemicals/fluoxetine/fluoxetine_final.pdf" rel="nofollow">http://cerhr.niehs.nih.gov/chemicals/fluoxetine/fluoxetine_final.pdf</a></span></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=NTP_CERHR+Expert+Panel+Report+on+Reproductive+and+Developmental+Toxicity+of+fluoxetine&amp;rft.date=April+2004&amp;rft.pub=Center+for+the+Evaluation+of+Risks+to+Human+Reproduction&amp;rft_id=http%3A%2F%2Fcerhr.niehs.nih.gov%2Fchemicals%2Ffluoxetine%2Ffluoxetine_final.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid2549018-22">^ <a href="#cite_ref-pmid2549018_22-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid2549018_22-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFLipinski_JF.2C_Mallya_G.2C_Zimmerman_P.2C_Pope_HG1989">Lipinski JF, Mallya G, Zimmerman P, Pope HG (1989). "Fluoxetine-induced akathisia: clinical and theoretical implications". <i>J Clin Psychiatry</i> <b>50</b> (9): 339–42. <a href="http://www.ncbi.nlm.nih.gov/pubmed/2549018" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/2549018">PMID 2549018</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Fluoxetine-induced+akathisia%3A+clinical+and+theoretical+implications&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Lipinski+JF%2C+Mallya+G%2C+Zimmerman+P%2C+Pope+HG&amp;rft.au=Lipinski+JF%2C+Mallya+G%2C+Zimmerman+P%2C+Pope+HG&amp;rft.date=1989&amp;rft.volume=50&amp;rft.issue=9&amp;rft.pages=339%E2%80%9342&amp;rft_id=info:pmid/2549018&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid8909330-23">^ <a href="#cite_ref-pmid8909330_23-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid8909330_23-1" title=""><sup><i><b>b</b></i></sup></a> Review:<cite style="font-style:normal" class="" id="CITEREFLeo_RJ1996">Leo RJ (1996). "Movement disorders associated with the serotonin selective reuptake inhibitors". <i>The Journal of clinical psychiatry</i> <b>57</b> (10): 449–54. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8909330" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8909330">PMID 8909330</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Movement+disorders+associated+with+the+serotonin+selective+reuptake+inhibitors&amp;rft.jtitle=The+Journal+of+clinical+psychiatry&amp;rft.aulast=Leo+RJ&amp;rft.au=Leo+RJ&amp;rft.date=1996&amp;rft.volume=57&amp;rft.issue=10&amp;rft.pages=449%E2%80%9354&amp;rft_id=info:pmid/8909330&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid14870959-24"><b><a href="#cite_ref-pmid14870959_24-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHansen_L2003">Hansen L (2003). "Fluoxetine dose-increment related akathisia in depression: implications for clinical care, recognition and management of selective serotonin reuptake inhibitor-induced akathisia". <i>J. Psychopharmacol. (Oxford)</i> <b>17</b> (4): 451–2. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14870959" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14870959">PMID 14870959</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Fluoxetine+dose-increment+related+akathisia+in+depression%3A+implications+for+clinical+care%2C+recognition+and+management+of+selective+serotonin+reuptake+inhibitor-induced+akathisia&amp;rft.jtitle=J.+Psychopharmacol.+%28Oxford%29&amp;rft.aulast=Hansen+L&amp;rft.au=Hansen+L&amp;rft.date=2003&amp;rft.volume=17&amp;rft.issue=4&amp;rft.pages=451%E2%80%932&amp;rft_id=info:pmid/14870959&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid1752848-25">^ <a href="#cite_ref-pmid1752848_25-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid1752848_25-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFRothschild_AJ.2C_Locke_CA1991">Rothschild AJ, Locke CA (1991). "Reexposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia". <i>J Clin Psychiatry</i> <b>52</b> (12): 491–3. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1752848" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/1752848">PMID 1752848</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Reexposure+to+fluoxetine+after+serious+suicide+attempts+by+three+patients%3A+the+role+of+akathisia&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Rothschild+AJ%2C+Locke+CA&amp;rft.au=Rothschild+AJ%2C+Locke+CA&amp;rft.date=1991&amp;rft.volume=52&amp;rft.issue=12&amp;rft.pages=491%E2%80%933&amp;rft_id=info:pmid/1752848&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12404546-26"><b><a href="#cite_ref-pmid12404546_26-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHansen_L2001">Hansen L (2001). "A critical review of akathisia, and its possible association with suicidal behaviour". <i>Human Psychopharmacology Clinical and Experimental</i> <b>16</b> (7): 495–505. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fhup.325" class="external text" title="http://dx.doi.org/10.1002%2Fhup.325" rel="nofollow">10.1002/hup.325</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12404546" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12404546">PMID 12404546</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+critical+review+of+akathisia%2C+and+its+possible+association+with+suicidal+behaviour&amp;rft.jtitle=Human+Psychopharmacology+Clinical+and+Experimental&amp;rft.aulast=Hansen+L&amp;rft.au=Hansen+L&amp;rft.date=2001&amp;rft.volume=16&amp;rft.issue=7&amp;rft.pages=495%E2%80%93505&amp;rft_id=info:doi/10.1002%2Fhup.325&amp;rft_id=info:pmid/12404546&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16449715-27"><b><a href="#cite_ref-pmid16449715_27-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHansen_L.2C_Kingdom_D2006">Hansen L, Kingdom D (2006). "Akathisia as a risk factor for suicide". <i>The British journal of psychiatry: the journal of mental science</i> <b>188</b>: 192. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1192%2Fbjp.188.2.192" class="external text" title="http://dx.doi.org/10.1192%2Fbjp.188.2.192" rel="nofollow">10.1192/bjp.188.2.192</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16449715" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16449715">PMID 16449715</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Akathisia+as+a+risk+factor+for+suicide&amp;rft.jtitle=The+British+journal+of+psychiatry%3A+the+journal+of+mental+science&amp;rft.aulast=Hansen+L%2C+Kingdom+D&amp;rft.au=Hansen+L%2C+Kingdom+D&amp;rft.date=2006&amp;rft.volume=188&amp;rft.pages=192&amp;rft_id=info:doi/10.1192%2Fbjp.188.2.192&amp;rft_id=info:pmid/16449715&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-28"><b><a href="#cite_ref-28" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGerber_PE.2C_Lynd_LD1998">Gerber PE, Lynd LD (1998). "Selective serotonin-reuptake inhibitor-induced movement disorders". <i>Ann Pharmacother</i> <b>32</b> (6): 692–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9640489" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9640489">PMID 9640489</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Selective+serotonin-reuptake+inhibitor-induced+movement+disorders&amp;rft.jtitle=Ann+Pharmacother&amp;rft.aulast=Gerber+PE%2C+Lynd+LD&amp;rft.au=Gerber+PE%2C+Lynd+LD&amp;rft.date=1998&amp;rft.volume=32&amp;rft.issue=6&amp;rft.pages=692%E2%80%938&amp;rft_id=info:pmid/9640489&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-29"><b><a href="#cite_ref-29" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCaley_CF1997">Caley CF (1997). "Extrapyramidal reactions and the selective serotonin-reuptake inhibitors". <i>Ann Pharmacother</i> <b>31</b> (12): 1481–9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9416386" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9416386">PMID 9416386</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Extrapyramidal+reactions+and+the+selective+serotonin-reuptake+inhibitors&amp;rft.jtitle=Ann+Pharmacother&amp;rft.aulast=Caley+CF&amp;rft.au=Caley+CF&amp;rft.date=1997&amp;rft.volume=31&amp;rft.issue=12&amp;rft.pages=1481%E2%80%939&amp;rft_id=info:pmid/9416386&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-insert-30"><b><a href="#cite_ref-insert_30-0" title="">^</a></b> Prozac Medication Insert. <a href="/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company">Eli Lilly and Company</a> Indianapolis, IN 46285, USA Literature revised December 4, 2006</li>
<li id="cite_note-31"><b><a href="#cite_ref-31" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.merck.com/mmpe/lexicomp/fluoxetine.html#NA7E33" class="external text" title="http://www.merck.com/mmpe/lexicomp/fluoxetine.html#NA7E33" rel="nofollow">"Fluoxetine Drug Information Provided by Lexi-Comp"</a>. Merck Manual. June 2007<span class="printonly">. <a href="http://www.merck.com/mmpe/lexicomp/fluoxetine.html#NA7E33" class="external free" title="http://www.merck.com/mmpe/lexicomp/fluoxetine.html#NA7E33" rel="nofollow">http://www.merck.com/mmpe/lexicomp/fluoxetine.html#NA7E33</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Fluoxetine+Drug+Information+Provided+by+Lexi-Comp&amp;rft.atitle=&amp;rft.date=June+2007&amp;rft.pub=Merck+Manual&amp;rft_id=http%3A%2F%2Fwww.merck.com%2Fmmpe%2Flexicomp%2Ffluoxetine.html%23NA7E33&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17913343-32">^ <a href="#cite_ref-pmid17913343_32-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17913343_32-1" title=""><sup><i><b>b</b></i></sup></a> The most recent case report, see <cite style="font-style:normal" class="" id="CITEREFBlum_D.2C_Maldonado_J.2C_Meyer_E.2C_Lansberg_M2008">Blum D, Maldonado J, Meyer E, Lansberg M (2008). "Delirium following abrupt discontinuation of fluoxetine". <i>Clin Neurol Neurosurg</i> <b>110</b> (1): 69–70. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.clineuro.2007.08.016" class="external text" title="http://dx.doi.org/10.1016%2Fj.clineuro.2007.08.016" rel="nofollow">10.1016/j.clineuro.2007.08.016</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17913343" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17913343">PMID 17913343</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Delirium+following+abrupt+discontinuation+of+fluoxetine&amp;rft.jtitle=Clin+Neurol+Neurosurg&amp;rft.aulast=Blum+D%2C+Maldonado+J%2C+Meyer+E%2C+Lansberg+M&amp;rft.au=Blum+D%2C+Maldonado+J%2C+Meyer+E%2C+Lansberg+M&amp;rft.date=2008&amp;rft.volume=110&amp;rft.issue=1&amp;rft.pages=69%E2%80%9370&amp;rft_id=info:doi/10.1016%2Fj.clineuro.2007.08.016&amp;rft_id=info:pmid/17913343&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span>For the earlier case reports see the references cited therein.</li>
<li id="cite_note-pmid9219493-33"><b><a href="#cite_ref-pmid9219493_33-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRosenbaum_JF.2C_Zajecka_J1997">Rosenbaum JF, Zajecka J (1997). "Clinical management of antidepressant discontinuation". <i>J Clin Psychiatry</i> <b>58 Suppl 7</b>: 37–40. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9219493" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9219493">PMID 9219493</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Clinical+management+of+antidepressant+discontinuation&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Rosenbaum+JF%2C+Zajecka+J&amp;rft.au=Rosenbaum+JF%2C+Zajecka+J&amp;rft.date=1997&amp;rft.volume=58+Suppl+7&amp;rft.pages=37%E2%80%9340&amp;rft_id=info:pmid/9219493&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16683860-34"><b><a href="#cite_ref-pmid16683860_34-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSchatzberg_AF.2C_Blier_P.2C_Delgado_PL.2C_Fava_M.2C_Haddad_PM.2C_Shelton_RC2006">Schatzberg AF, Blier P, Delgado PL, Fava M, Haddad PM, Shelton RC (2006). "Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research". <i>J Clin Psychiatry</i> <b>67 Suppl 4</b>: 27–30. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16683860" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16683860">PMID 16683860</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Antidepressant+discontinuation+syndrome%3A+consensus+panel+recommendations+for+clinical+management+and+additional+research&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Schatzberg+AF%2C+Blier+P%2C+Delgado+PL%2C+Fava+M%2C+Haddad+PM%2C+Shelton+RC&amp;rft.au=Schatzberg+AF%2C+Blier+P%2C+Delgado+PL%2C+Fava+M%2C+Haddad+PM%2C+Shelton+RC&amp;rft.date=2006&amp;rft.volume=67+Suppl+4&amp;rft.pages=27%E2%80%9330&amp;rft_id=info:pmid/16683860&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16683858-35"><b><a href="#cite_ref-pmid16683858_35-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFava_M2006">Fava M (2006). "Prospective studies of adverse events related to antidepressant discontinuation". <i>J Clin Psychiatry</i> <b>67 Suppl 4</b>: 14–21. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16683858" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16683858">PMID 16683858</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Prospective+studies+of+adverse+events+related+to+antidepressant+discontinuation&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Fava+M&amp;rft.au=Fava+M&amp;rft.date=2006&amp;rft.volume=67+Suppl+4&amp;rft.pages=14%E2%80%9321&amp;rft_id=info:pmid/16683858&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9617977-36"><b><a href="#cite_ref-pmid9617977_36-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFZajecka_J.2C_Fawcett_J.2C_Amsterdam_J.2C_Quitkin_F.2C_Reimherr_F.2C_Rosenbaum_J.2C_Michelson_D.2C_Beasley_C1998">Zajecka J, Fawcett J, Amsterdam J, Quitkin F, Reimherr F, Rosenbaum J, Michelson D, Beasley C (1998). "Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study". <i>J Clin Psychopharmacol</i> <b>18</b> (3): 193–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9617977" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9617977">PMID 9617977</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Safety+of+abrupt+discontinuation+of+fluoxetine%3A+a+randomized%2C+placebo-controlled+study&amp;rft.jtitle=J+Clin+Psychopharmacol&amp;rft.aulast=Zajecka+J%2C+Fawcett+J%2C+Amsterdam+J%2C+Quitkin+F%2C+Reimherr+F%2C+Rosenbaum+J%2C+Michelson+D%2C+Beasley+C&amp;rft.au=Zajecka+J%2C+Fawcett+J%2C+Amsterdam+J%2C+Quitkin+F%2C+Reimherr+F%2C+Rosenbaum+J%2C+Michelson+D%2C+Beasley+C&amp;rft.date=1998&amp;rft.volume=18&amp;rft.issue=3&amp;rft.pages=193%E2%80%937&amp;rft_id=info:pmid/9617977&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-FDA-37"><b><a href="#cite_ref-FDA_37-0" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFLevenson_M.2C_Holland_C">Levenson M, Holland C. <a href="http://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4272s1-04-FDA.ppt" class="external text" title="http://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4272s1-04-FDA.ppt" rel="nofollow">"Antidepressants and Suicidality in Adults: Statistical Evaluation. (Presentation at Psychopharmacologic Drugs Advisory Committee; December 13, 2006)"</a><span class="printonly">. <a href="http://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4272s1-04-FDA.ppt" class="external free" title="http://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4272s1-04-FDA.ppt" rel="nofollow">http://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4272s1-04-FDA.ppt</a></span><span class="reference-accessdate">. Retrieved on 2007-05-13</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Antidepressants+and+Suicidality+in+Adults%3A+Statistical+Evaluation.+%28Presentation+at+Psychopharmacologic+Drugs+Advisory+Committee%3B+December+13%2C+2006%29&amp;rft.atitle=&amp;rft.aulast=Levenson+M%2C+Holland+C&amp;rft.au=Levenson+M%2C+Holland+C&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fohrms%2Fdockets%2Fac%2F06%2Fslides%2F2006-4272s1-04-FDA.ppt&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-FDA2-38">^ <a href="#cite_ref-FDA2_38-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA2_38-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="web" id="CITEREFStone_MB.2C_Jones_ML2006">Stone MB, Jones ML (2006-11-17). <a href="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" class="external text" title="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" rel="nofollow">"Clinical Review: Relationship Between Antidepressant Drugs and Suicidality in Adults"</a> (PDF). <i>Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC)</i>. FDA. 11-74<span class="printonly">. <a href="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" class="external free" title="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" rel="nofollow">http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf</a></span><span class="reference-accessdate">. Retrieved on 2007-09-22</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Clinical+Review%3A+Relationship+Between+Antidepressant+Drugs+and+Suicidality+in+Adults&amp;rft.atitle=Overview+for+December+13+Meeting+of+Psychopharmacologic+Drugs+Advisory+Committee+%28PDAC%29&amp;rft.aulast=Stone+MB%2C+Jones+ML&amp;rft.au=Stone+MB%2C+Jones+ML&amp;rft.date=2006-11-17&amp;rft.pages=11-74&amp;rft.pub=FDA&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fohrms%2Fdockets%2Fac%2F06%2Fbriefing%2F2006-4272b1-01-FDA.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-FDA3-39">^ <a href="#cite_ref-FDA3_39-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA3_39-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="web" id="CITEREFLevenson_M.2C_Holland_C2006">Levenson M, Holland C (2006-11-17). <a href="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" class="external text" title="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" rel="nofollow">"Statistical Evaluation of Suicidality in Adults Treated with Antidepressants"</a> (PDF). <i>Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC)</i>. FDA. 75-140<span class="printonly">. <a href="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" class="external free" title="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" rel="nofollow">http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf</a></span><span class="reference-accessdate">. Retrieved on 2007-09-22</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Statistical+Evaluation+of+Suicidality+in+Adults+Treated+with+Antidepressants&amp;rft.atitle=Overview+for+December+13+Meeting+of+Psychopharmacologic+Drugs+Advisory+Committee+%28PDAC%29&amp;rft.aulast=Levenson+M%2C+Holland+C&amp;rft.au=Levenson+M%2C+Holland+C&amp;rft.date=2006-11-17&amp;rft.pages=75-140&amp;rft.pub=FDA&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fohrms%2Fdockets%2Fac%2F06%2Fbriefing%2F2006-4272b1-01-FDA.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16395296-40"><b><a href="#cite_ref-pmid16395296_40-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKlein_DF2006">Klein DF (2006). "The flawed basis for FDA post-marketing safety decisions: the example of anti-depressants and children". <i>Neuropsychopharmacology</i> <b>31</b> (4): 689–99. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2Fsj.npp.1300996" class="external text" title="http://dx.doi.org/10.1038%2Fsj.npp.1300996" rel="nofollow">10.1038/sj.npp.1300996</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16395296" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16395296">PMID 16395296</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+flawed+basis+for+FDA+post-marketing+safety+decisions%3A+the+example+of+anti-depressants+and+children&amp;rft.jtitle=Neuropsychopharmacology&amp;rft.aulast=Klein+DF&amp;rft.au=Klein+DF&amp;rft.date=2006&amp;rft.volume=31&amp;rft.issue=4&amp;rft.pages=689%E2%80%9399&amp;rft_id=info:doi/10.1038%2Fsj.npp.1300996&amp;rft_id=info:pmid/16395296&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18190232-41"><b><a href="#cite_ref-pmid18190232_41-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMann_JJ.2C_Ellis_SP.2C_Waternaux_CM.2C_Liu_X.2C_Oquendo_MA.2C_Malone_KM.2C_Brodsky_BS.2C_Haas_GL.2C_Currier_D2008">Mann JJ, Ellis SP, Waternaux CM, Liu X, Oquendo MA, Malone KM, Brodsky BS, Haas GL, Currier D (2008). "Classification Trees Distinguish Suicide Attempters in Major Psychiatric Disorders: A Model of Clinical Decision Making". <i>J Clin Psychiatry</i>: e1–e9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18190232" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18190232">PMID 18190232</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Classification+Trees+Distinguish+Suicide+Attempters+in+Major+Psychiatric+Disorders%3A+A+Model+of+Clinical+Decision+Making&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Mann+JJ%2C+Ellis+SP%2C+Waternaux+CM%2C+Liu+X%2C+Oquendo+MA%2C+Malone+KM%2C+Brodsky+BS%2C+Haas+GL%2C+Currier+D&amp;rft.au=Mann+JJ%2C+Ellis+SP%2C+Waternaux+CM%2C+Liu+X%2C+Oquendo+MA%2C+Malone+KM%2C+Brodsky+BS%2C+Haas+GL%2C+Currier+D&amp;rft.date=2008&amp;rft.pages=e1%E2%80%93e9&amp;rft_id=info:pmid/18190232&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-FDA4-42"><b><a href="#cite_ref-FDA4_42-0" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFTarek_A._Hammad2004">Tarek A. Hammad (2004-09-13). <a href="http://www.fda.gov/ohrms/dockets/ac/04/slides/2004-4065S1_08_FDA-Hammad.ppt" class="external text" title="http://www.fda.gov/ohrms/dockets/ac/04/slides/2004-4065S1_08_FDA-Hammad.ppt" rel="nofollow">"Results of the Analysis of Suicidality in Pediatric Trials of Newer Antidepressants"</a> (PDF). <i>Presentation at the Meeting of Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee on September 13, 2004</i>. FDA. 25, 28<span class="printonly">. <a href="http://www.fda.gov/ohrms/dockets/ac/04/slides/2004-4065S1_08_FDA-Hammad.ppt" class="external free" title="http://www.fda.gov/ohrms/dockets/ac/04/slides/2004-4065S1_08_FDA-Hammad.ppt" rel="nofollow">http://www.fda.gov/ohrms/dockets/ac/04/slides/2004-4065S1_08_FDA-Hammad.ppt</a></span><span class="reference-accessdate">. Retrieved on 2008-01-06</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Results+of+the+Analysis+of+Suicidality+in+Pediatric+Trials+of+Newer+Antidepressants&amp;rft.atitle=Presentation+at+the+Meeting+of+Psychopharmacologic+Drugs+Advisory+Committee+and+the+Pediatric+Advisory+Committee+on+September+13%2C+2004&amp;rft.aulast=Tarek+A.+Hammad&amp;rft.au=Tarek+A.+Hammad&amp;rft.date=2004-09-13&amp;rft.pages=25%2C+28&amp;rft.pub=FDA&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fohrms%2Fdockets%2Fac%2F04%2Fslides%2F2004-4065S1_08_FDA-Hammad.ppt&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-43"><b><a href="#cite_ref-43" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREF.5B.5BCommittee_on_Safety_of_Medicines.5D.5D_Expert_Working_Group2004"><a href="/wiki/Committee_on_Safety_of_Medicines" title="Committee on Safety of Medicines">Committee on Safety of Medicines</a> Expert Working Group (December 2004). <a href="http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf" class="external text" title="http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf" rel="nofollow">"Report on The Safety of Selective Serotonin Reuptake Inhibitor Antidepressants"</a> (PDF). <a href="/wiki/Medicines_and_Healthcare_products_Regulatory_Agency" title="Medicines and Healthcare products Regulatory Agency">MHRA</a><span class="printonly">. <a href="http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf" class="external free" title="http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf" rel="nofollow">http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf</a></span><span class="reference-accessdate">. Retrieved on 2007-09-25</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Report+on+The+Safety+of+Selective+Serotonin+Reuptake+Inhibitor+Antidepressants&amp;rft.atitle=&amp;rft.aulast=%5B%5BCommittee+on+Safety+of+Medicines%5D%5D+Expert+Working+Group&amp;rft.au=%5B%5BCommittee+on+Safety+of+Medicines%5D%5D+Expert+Working+Group&amp;rft.date=December+2004&amp;rft.pub=%5B%5BMedicines+and+Healthcare+products+Regulatory+Agency%7CMHRA%5D%5D&amp;rft_id=http%3A%2F%2Fwww.mhra.gov.uk%2Fhome%2Fgroups%2Fpl-p%2Fdocuments%2Fdrugsafetymessage%2Fcon019472.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15718537-44"><b><a href="#cite_ref-pmid15718537_44-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGunnell_D.2C_Saperia_J.2C_Ashby_D2005">Gunnell D, Saperia J, Ashby D (2005). "Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review". <i>BMJ</i> <b>330</b> (7488): 385. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fbmj.330.7488.385" class="external text" title="http://dx.doi.org/10.1136%2Fbmj.330.7488.385" rel="nofollow">10.1136/bmj.330.7488.385</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15718537" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15718537">PMID 15718537</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Selective+serotonin+reuptake+inhibitors+%28SSRIs%29+and+suicide+in+adults%3A+meta-analysis+of+drug+company+data+from+placebo+controlled%2C+randomised+controlled+trials+submitted+to+the+MHRA%27s+safety+review&amp;rft.jtitle=BMJ&amp;rft.aulast=Gunnell+D%2C+Saperia+J%2C+Ashby+D&amp;rft.au=Gunnell+D%2C+Saperia+J%2C+Ashby+D&amp;rft.date=2005&amp;rft.volume=330&amp;rft.issue=7488&amp;rft.pages=385&amp;rft_id=info:doi/10.1136%2Fbmj.330.7488.385&amp;rft_id=info:pmid/15718537&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Sandson-45">^ <a href="#cite_ref-Sandson_45-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Sandson_45-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFSandson_NB.2C_Armstrong_SC.2C_Cozza_KL2005">Sandson NB, Armstrong SC, Cozza KL (2005). "An overview of psychotropic drug-drug interactions". <i>Psychosomatics</i> <b>46</b> (5): 464–94. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.psy.46.5.464" class="external text" title="http://dx.doi.org/10.1176%2Fappi.psy.46.5.464" rel="nofollow">10.1176/appi.psy.46.5.464</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16145193" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16145193">PMID 16145193</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=An+overview+of+psychotropic+drug-drug+interactions&amp;rft.jtitle=Psychosomatics&amp;rft.aulast=Sandson+NB%2C+Armstrong+SC%2C+Cozza+KL&amp;rft.au=Sandson+NB%2C+Armstrong+SC%2C+Cozza+KL&amp;rft.date=2005&amp;rft.volume=46&amp;rft.issue=5&amp;rft.pages=464%E2%80%9394&amp;rft_id=info:doi/10.1176%2Fappi.psy.46.5.464&amp;rft_id=info:pmid/16145193&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-46"><b><a href="#cite_ref-46" title="">^</a></b> An extensive list of possible interactions is available in <cite style="font-style:normal" class="web" id="CITEREFLexi-Comp2008">Lexi-Comp (September 2008). <a href="http://www.merck.com/mmpe/lexicomp/fluoxetine.html" class="external text" title="http://www.merck.com/mmpe/lexicomp/fluoxetine.html" rel="nofollow">"Fluoxetine"</a>. <i><a href="/wiki/Merck_Manual_of_Diagnosis_and_Therapy" title="Merck Manual of Diagnosis and Therapy">The Merck Manual Professional</a></i><span class="printonly">. <a href="http://www.merck.com/mmpe/lexicomp/fluoxetine.html" class="external free" title="http://www.merck.com/mmpe/lexicomp/fluoxetine.html" rel="nofollow">http://www.merck.com/mmpe/lexicomp/fluoxetine.html</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Fluoxetine&amp;rft.atitle=%5B%5BMerck+Manual+of+Diagnosis+and+Therapy%7CThe+Merck+Manual+Professional%5D%5D&amp;rft.aulast=Lexi-Comp&amp;rft.au=Lexi-Comp&amp;rft.date=September+2008&amp;rft_id=http%3A%2F%2Fwww.merck.com%2Fmmpe%2Flexicomp%2Ffluoxetine.html&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span> Retrieved on December 28, 2008.</li>
<li id="cite_note-47"><b><a href="#cite_ref-47" title="">^</a></b> Healy D (2004) Let them eat Prozac. New York: <a href="/wiki/New_York_University" title="New York University">New York University</a> Press. pp 124–148.</li>
<li id="cite_note-48"><b><a href="#cite_ref-48" title="">^</a></b> <a href="http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0030372&amp;ct=1" class="external text" title="http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0030372&amp;ct=1" rel="nofollow">Antidepressants and Violence: Problems at the Interface of Medicine and Law</a>, David Healy, Andrew Herxheimer, and David B. Menkes, PLoS Med 3(9): e372 doi:10.1371/journal.pmed.0030372, 2006</li>
<li id="cite_note-49"><b><a href="#cite_ref-49" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFKirsch_I.2C_Deacon_BJ.2C_Huedo-Medina_TB.2C_Scoboria_A.2C_Moore_TJ.2C_Johnson_BT2008">Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT (February 2008). <a href="http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0050045" class="external text" title="http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0050045" rel="nofollow">"Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration"</a> (htm). PLoS Medicine<span class="printonly">. <a href="http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0050045" class="external free" title="http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0050045" rel="nofollow">http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0050045</a></span><span class="reference-accessdate">. Retrieved on 2008-02-26</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Initial+Severity+and+Antidepressant+Benefits%3A+A+Meta-Analysis+of+Data+Submitted+to+the+Food+and+Drug+Administration&amp;rft.atitle=&amp;rft.aulast=Kirsch+I%2C+Deacon+BJ%2C+Huedo-Medina+TB%2C+Scoboria+A%2C+Moore+TJ%2C+Johnson+BT&amp;rft.au=Kirsch+I%2C+Deacon+BJ%2C+Huedo-Medina+TB%2C+Scoboria+A%2C+Moore+TJ%2C+Johnson+BT&amp;rft.date=February+2008&amp;rft.pub=PLoS+Medicine&amp;rft_id=http%3A%2F%2Fmedicine.plosjournals.org%2Fperlserv%2F%3Frequest%3Dget-document%26doi%3D10.1371%2Fjournal.pmed.0050045&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-50"><b><a href="#cite_ref-50" title="">^</a></b> <cite style="font-style:normal" class="news"><a href="http://www.guardian.co.uk/society/2008/feb/27/mentalhealth.health1" class="external text" title="http://www.guardian.co.uk/society/2008/feb/27/mentalhealth.health1" rel="nofollow">"The creation of the Prozac myth"</a>. The Guardian. February 27 2008<span class="printonly">. <a href="http://www.guardian.co.uk/society/2008/feb/27/mentalhealth.health1" class="external free" title="http://www.guardian.co.uk/society/2008/feb/27/mentalhealth.health1" rel="nofollow">http://www.guardian.co.uk/society/2008/feb/27/mentalhealth.health1</a></span><span class="reference-accessdate">. Retrieved on 2008-03-01</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=The+creation+of+the+Prozac+myth&amp;rft.atitle=&amp;rft.date=February+27+2008&amp;rft.pub=The+Guardian&amp;rft_id=http%3A%2F%2Fwww.guardian.co.uk%2Fsociety%2F2008%2Ffeb%2F27%2Fmentalhealth.health1&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-51"><b><a href="#cite_ref-51" title="">^</a></b> <cite style="font-style:normal" class="news" id="CITEREFDay2008">Day, Michael (2008-02-26). <a href="http://www.newscientist.com/article/dn13375-prozac-does-not-work-in-most-depressed-patients.html" class="external text" title="http://www.newscientist.com/article/dn13375-prozac-does-not-work-in-most-depressed-patients.html" rel="nofollow">"Prozac does not work in majority of depressed patients"</a>. New Scientist<span class="printonly">. <a href="http://www.newscientist.com/article/dn13375-prozac-does-not-work-in-most-depressed-patients.html" class="external free" title="http://www.newscientist.com/article/dn13375-prozac-does-not-work-in-most-depressed-patients.html" rel="nofollow">http://www.newscientist.com/article/dn13375-prozac-does-not-work-in-most-depressed-patients.html</a></span><span class="reference-accessdate">. Retrieved on 2008-03-01</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Prozac+does+not+work+in+majority+of+depressed+patients&amp;rft.atitle=&amp;rft.aulast=Day&amp;rft.aufirst=Michael&amp;rft.au=Day%2C+Michael&amp;rft.date=2008-02-26&amp;rft.pub=New+Scientist&amp;rft_id=http%3A%2F%2Fwww.newscientist.com%2Farticle%2Fdn13375-prozac-does-not-work-in-most-depressed-patients.html&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-52"><b><a href="#cite_ref-52" title="">^</a></b> <cite style="font-style:normal" class="news" id="CITEREFBlue2008">Blue, Laura (February 26, 2008). <a href="http://www.time.com/time/health/article/0,8599,1717306,00.html" class="external text" title="http://www.time.com/time/health/article/0,8599,1717306,00.html" rel="nofollow">"Antidepressants Hardly Help"</a><span class="printonly">. <a href="http://www.time.com/time/health/article/0,8599,1717306,00.html" class="external free" title="http://www.time.com/time/health/article/0,8599,1717306,00.html" rel="nofollow">http://www.time.com/time/health/article/0,8599,1717306,00.html</a></span><span class="reference-accessdate">. Retrieved on 2008-03-01</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Antidepressants+Hardly+Help&amp;rft.atitle=&amp;rft.aulast=Blue&amp;rft.aufirst=Laura&amp;rft.au=Blue%2C+Laura&amp;rft.date=February+26%2C+2008&amp;rft_id=http%3A%2F%2Fwww.time.com%2Ftime%2Fhealth%2Farticle%2F0%2C8599%2C1717306%2C00.html&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-53"><b><a href="#cite_ref-53" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJohnson_BT.3B_Kirsch_I2008">Johnson BT; Kirsch I (June 2008). "<a href="http://www.ingentaconnect.com/content/bpl/sign/2008/00000005/00000002/art00002" class="external text" title="http://www.ingentaconnect.com/content/bpl/sign/2008/00000005/00000002/art00002" rel="nofollow">Do antidepressants work? Statistical significance versus clinical benefits</a>". <i>Significance</i> <b>5</b> (2): 54-58. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1740-9713.2008.00286.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1740-9713.2008.00286.x" rel="nofollow">10.1111/j.1740-9713.2008.00286.x</a></span><span class="printonly">. <a href="http://www.ingentaconnect.com/content/bpl/sign/2008/00000005/00000002/art00002" class="external free" title="http://www.ingentaconnect.com/content/bpl/sign/2008/00000005/00000002/art00002" rel="nofollow">http://www.ingentaconnect.com/content/bpl/sign/2008/00000005/00000002/art00002</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Do+antidepressants+work%3F+Statistical+significance+versus+clinical+benefits&amp;rft.jtitle=Significance&amp;rft.aulast=Johnson+BT%3B+Kirsch+I&amp;rft.au=Johnson+BT%3B+Kirsch+I&amp;rft.date=June+2008&amp;rft.volume=5&amp;rft.issue=2&amp;rft.pages=54-58&amp;rft_id=info:doi/10.1111%2Fj.1740-9713.2008.00286.x&amp;rft_id=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fbpl%2Fsign%2F2008%2F00000005%2F00000002%2Fart00002&amp;rfr_id=info:sid/en.wikipedia.org:Fluoxetine"><span style="display: none;">&#160;</span></span></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Fluoxetine&amp;action=edit&amp;section=12" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.nature.com/drugdisc/nj/articles/nrd1811.html" class="external text" title="http://www.nature.com/drugdisc/nj/articles/nrd1811.html" rel="nofollow">Biography of Dr. David T. Wong, one of the inventors of Prozac</a></li>
<li><a href="http://www.invent.org/hall_of_fame/105.html" class="external text" title="http://www.invent.org/hall_of_fame/105.html" rel="nofollow">Biography of Dr. Bryan B. Molloy, one of the inventors of Prozac</a></li>
<li><a href="http://money.cnn.com/magazines/fortune/fortune_archive/2005/11/28/8361973/index.htm" class="external text" title="http://money.cnn.com/magazines/fortune/fortune_archive/2005/11/28/8361973/index.htm" rel="nofollow">Trouble in Prozac - Fortune Magazine</a></li>
</ul>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;;border:none;; font-size:xx-small;"><a href="/wiki/Template:Antidepressants" title="Template:Antidepressants"><span title="View this template" style=";;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Antidepressants" title="Template talk:Antidepressants"><span title="Discussion about this template" style=";;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Antidepressants&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Antidepressants&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Psychoanaleptic" title="Psychoanaleptic">Psychoanaleptics</a>: <a href="/wiki/Antidepressant" title="Antidepressant">antidepressants</a> (<a href="/wiki/ATC_code_N06#N06A_Antidepressants" title="ATC code N06">N06A</a>)</span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Monoamine_oxidase_inhibitor" title="Monoamine oxidase inhibitor">MAOIs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i>nonselective:</i> <i>non-reversible</i> (<a href="/wiki/Isocarboxazid" title="Isocarboxazid">Isocarboxazid</a>, <a href="/wiki/Iproclozide" title="Iproclozide">Iproclozide</a>, <a href="/wiki/Iproniazid" title="Iproniazid">Iproniazid</a>, <a href="/wiki/Nialamide" title="Nialamide">Nialamide</a>, <a href="/wiki/Phenelzine" title="Phenelzine">Phenelzine</a>, <a href="/wiki/Pheniprazine" title="Pheniprazine">Pheniprazine</a>) • <i>reversible</i> (<a href="/wiki/Tranylcypromine" title="Tranylcypromine">Tranylcypromine</a>)
<p><i><a href="/wiki/Monoamine_oxidase_A" title="Monoamine oxidase A">MAOA</a> (<a href="/wiki/Norepinephrine" title="Norepinephrine">N</a>/<a href="/wiki/Serotonin" title="Serotonin">S</a>):</i> <a href="/wiki/Clorgiline" title="Clorgiline">Clorgiline</a> • <a href="/wiki/Minaprine" title="Minaprine">Minaprine</a> • <i><a href="/wiki/Reversible_inhibitor_of_monoamine_oxidase_A" title="Reversible inhibitor of monoamine oxidase A">RIMAs</a></i> (<a href="/wiki/Befloxatone" title="Befloxatone">Befloxatone</a>, <a href="/wiki/Brofaromine" title="Brofaromine">Brofaromine</a>, <a href="/wiki/Cimoxatone" title="Cimoxatone">Cimoxatone</a>, <a href="/wiki/Harmaline" title="Harmaline">Harmaline</a>, <a href="/wiki/Moclobemide" title="Moclobemide">Moclobemide</a>, <a href="/wiki/Pirlindole" title="Pirlindole">Pirlindole</a>, <a href="/wiki/Toloxatone" title="Toloxatone">Toloxatone</a>)</p>
<i><a href="/wiki/Monoamine_oxidase_B" title="Monoamine oxidase B">MAOB</a> (<a href="/wiki/Dopamine" title="Dopamine">D</a>):</i> <a href="/wiki/Rasagiline" title="Rasagiline">Rasagiline</a> • <a href="/wiki/Selegiline" title="Selegiline">Selegiline</a> • <a href="/wiki/Pargyline" title="Pargyline">Pargyline</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Neurotransmitter_uptake_inhibitor" title="Neurotransmitter uptake inhibitor">RIs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Serotonin_uptake_inhibitor" title="Serotonin uptake inhibitor">S RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Selective_serotonin_reuptake_inhibitor" title="Selective serotonin reuptake inhibitor">SS RI</a> (<a href="/wiki/Alaproclate" title="Alaproclate">Alaproclate</a>, <a href="/wiki/Citalopram" title="Citalopram">Citalopram</a>, <a href="/wiki/Dapoxetine" title="Dapoxetine">Dapoxetine</a>, <a href="/wiki/Escitalopram" title="Escitalopram">Escitalopram</a>, <a href="/wiki/Femoxetine" title="Femoxetine">Femoxetine</a>, <strong class="selflink">Fluoxetine</strong>, <a href="/wiki/Fluvoxamine" title="Fluvoxamine">Fluvoxamine</a>, <a href="/wiki/Paroxetine" title="Paroxetine">Paroxetine</a>, <a href="/wiki/Sertraline" title="Sertraline">Sertraline</a>, <a href="/wiki/Vilazodone" title="Vilazodone">Vilazodone</a>, <a href="/wiki/Zimelidine" title="Zimelidine">Zimelidine</a>)<br />
<i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a>/<a href="/wiki/Tetracyclic_antidepressant" title="Tetracyclic antidepressant">Tetras</a></i> (<a href="/wiki/Cianopramine" title="Cianopramine">Cianopramine</a>, <a href="/wiki/Clomipramine" title="Clomipramine">Clomipramine</a>, <a href="/wiki/Nefazodone" title="Nefazodone">Nefazodone</a>, <a href="/wiki/Trazodone" title="Trazodone">Trazodone</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Norepinephrine_reuptake_inhibitor" title="Norepinephrine reuptake inhibitor">N RI</a> / <a href="/wiki/Adrenergic_uptake_inhibitor" title="Adrenergic uptake inhibitor">A RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Atomoxetine" title="Atomoxetine">Atomoxetine</a> • <a href="/wiki/Ciclazindol" title="Ciclazindol">Ciclazindol</a> • <a href="/wiki/Maprotiline" title="Maprotiline">Maprotiline</a> • <a href="/wiki/Nisoxetine" title="Nisoxetine">Nisoxetine</a> • <a href="/wiki/Oxaprotiline" title="Oxaprotiline">Oxaprotiline</a> • <a href="/wiki/Reboxetine" title="Reboxetine">Reboxetine</a> • <a href="/wiki/Talopram" title="Talopram">Talopram</a> • <a href="/wiki/Viloxazine" title="Viloxazine">Viloxazine</a><br />
<i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a>/<a href="/wiki/Tetracyclic_antidepressant" title="Tetracyclic antidepressant">Tetras</a></i> (<a href="/wiki/Amoxapine" title="Amoxapine">Amoxapine</a>, <a href="/wiki/Butriptyline" title="Butriptyline">Butriptyline</a>, <a href="/wiki/Desipramine" title="Desipramine">Desipramine</a>/<a href="/wiki/Lofepramine" title="Lofepramine">Lofepramine</a>, <a href="/wiki/Dibenzepin" title="Dibenzepin">Dibenzepin</a>, <a href="/wiki/Dosulepin_hydrochloride" title="Dosulepin hydrochloride">Dosulepin</a>, <a href="/wiki/Doxepin" title="Doxepin">Doxepin</a>, <a href="/wiki/Imipramine" title="Imipramine">Imipramine</a>, <a href="/wiki/Iprindole" title="Iprindole">Iprindole</a>, <a href="/wiki/Melitracen" title="Melitracen">Melitracen</a>, <a href="/wiki/Nitroxazepine" title="Nitroxazepine">Nitroxazepine</a>, <a href="/wiki/Nortriptyline" title="Nortriptyline">Nortriptyline</a>, <a href="/wiki/Protriptyline" title="Protriptyline">Protriptyline</a>, <a href="/wiki/Trimipramine" title="Trimipramine">Trimipramine</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dopamine_reuptake_inhibitor" title="Dopamine reuptake inhibitor">D RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Medifoxamine" title="Medifoxamine">Medifoxamine</a> • <a href="/wiki/Phenmetrazine" title="Phenmetrazine">Phenmetrazine</a> • <a href="/wiki/Vanoxerine" title="Vanoxerine">Vanoxerine</a><br />
<i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a></i> (<a href="/wiki/Amineptine" title="Amineptine">Amineptine</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Serotonin-norepinephrine_reuptake_inhibitor" title="Serotonin-norepinephrine reuptake inhibitor">SN RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Bicifadine" title="Bicifadine">Bicifadine</a> • <a href="/wiki/Clovoxamine" title="Clovoxamine">Clovoxamine</a> • <a href="/wiki/Desvenlafaxine" title="Desvenlafaxine">Desvenlafaxine</a> • <a href="/wiki/Duloxetine" title="Duloxetine">Duloxetine</a> • <a href="/wiki/Indeloxazine" title="Indeloxazine">Indeloxazine</a> • <a href="/wiki/Milnacipran" title="Milnacipran">Milnacipran</a> • <a href="/wiki/Nefazodone" title="Nefazodone">Nefazodone</a> • <a href="/wiki/Venlafaxine" title="Venlafaxine">Venlafaxine</a><br />
<i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a></i> (<a href="/wiki/Amitriptyline" title="Amitriptyline">Amitriptyline</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Norepinephrine-dopamine_reuptake_inhibitor" title="Norepinephrine-dopamine reuptake inhibitor">ND RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Bupropion" title="Bupropion">Bupropion</a> • <a href="/wiki/Nomifensine" title="Nomifensine">Nomifensine</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Serotonin-noradrenaline-dopamine_reuptake_inhibitor" title="Serotonin-noradrenaline-dopamine reuptake inhibitor">SND RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Brasofensine" title="Brasofensine">Brasofensine</a> • <a href="/wiki/Diclofensine" title="Diclofensine">Diclofensine</a> • <a href="/wiki/Tesofensine" title="Tesofensine">Tesofensine</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Selective_serotonin_reuptake_enhancer" title="Selective serotonin reuptake enhancer">SSREs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a></i> (<a href="/wiki/Tianeptine" title="Tianeptine">Tianeptine</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Adrenergic_antagonist" title="Adrenergic antagonist">AAs</a> at <a href="/wiki/Alpha-2_adrenergic_receptor" title="Alpha-2 adrenergic receptor">A2</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i><a href="/wiki/Tetracyclic_antidepressant" title="Tetracyclic antidepressant">Tetras</a></i> (<a href="/wiki/Mianserin" title="Mianserin">Mianserin</a>, <a href="/wiki/Mirtazapine" title="Mirtazapine">Mirtazapine</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Sigma_receptor#Agonists" title="Sigma receptor">SAs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a></i> (<a href="/wiki/Opipramol" title="Opipramol">Opipramol</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Melatonin_receptor" title="Melatonin receptor">MAs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i><a href="/wiki/Melatonin_receptor#Agonists" title="Melatonin receptor">Melatonin receptor agonists</a></i> (<a href="/wiki/Agomelatine" title="Agomelatine">Agomelatine</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Preprocessor node count: 26935/1000000
Post-expand include size: 263527/2048000 bytes
Template argument size: 107295/2048000 bytes
Expensive parser function count: 0/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:10153680-0!1!0!default!!en!2 and timestamp 20090404183335 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Fluoxetine">http://en.wikipedia.org/wiki/Fluoxetine</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Selective_serotonin_reuptake_inhibitors" title="Category:Selective serotonin reuptake inhibitors">Selective serotonin reuptake inhibitors</a></span> | <span dir='ltr'><a href="/wiki/Category:Eli_Lilly_and_Company" title="Category:Eli Lilly and Company">Eli Lilly and Company</a></span> | <span dir='ltr'><a href="/wiki/Category:World_Health_Organization_essential_medicines" title="Category:World Health Organization essential medicines">World Health Organization essential medicines</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Fluoxetine" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Fluoxetine" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Fluoxetine&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Fluoxetine&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Fluoxetine" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Fluoxetine" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Fluoxetine" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Fluoxetine&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Fluoxetine&amp;oldid=281743162" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Fluoxetine&amp;id=281743162">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-bg"><a href="http://bg.wikipedia.org/wiki/%D0%A4%D0%BB%D1%83%D0%BE%D0%BA%D1%81%D0%B5%D1%82%D0%B8%D0%BD">Български</a></li>
				<li class="interwiki-cs"><a href="http://cs.wikipedia.org/wiki/Fluoxetin">Česky</a></li>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Fluoxetin">Deutsch</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/Fluoxetina">Español</a></li>
				<li class="interwiki-eo"><a href="http://eo.wikipedia.org/wiki/Fluoksetino">Esperanto</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/Fluox%C3%A9tine">Français</a></li>
				<li class="interwiki-fa"><a href="http://fa.wikipedia.org/wiki/%D9%81%D9%84%D9%88%DA%A9%D8%B3%D8%AA%DB%8C%D9%86">فارسی</a></li>
				<li class="interwiki-ko"><a href="http://ko.wikipedia.org/wiki/%ED%94%8C%EB%A3%A8%EC%98%A5%EC%84%B8%ED%8B%B4">한국어</a></li>
				<li class="interwiki-it"><a href="http://it.wikipedia.org/wiki/Fluoxetina">Italiano</a></li>
				<li class="interwiki-he"><a href="http://he.wikipedia.org/wiki/SSRI#.D7.AA.D7.A8.D7.95.D7.A4.D7.95.D7.AA_.D7.9E.D7.9E.D7.A9.D7.A4.D7.97.D7.AA_SSRI">עברית</a></li>
				<li class="interwiki-hu"><a href="http://hu.wikipedia.org/wiki/Fluoxetin">Magyar</a></li>
				<li class="interwiki-nl"><a href="http://nl.wikipedia.org/wiki/Fluoxetine">Nederlands</a></li>
				<li class="interwiki-ja"><a href="http://ja.wikipedia.org/wiki/%E3%83%95%E3%83%AB%E3%82%AA%E3%82%AD%E3%82%BB%E3%83%81%E3%83%B3">日本語</a></li>
				<li class="interwiki-no"><a href="http://no.wikipedia.org/wiki/Fluoksetin">‪Norsk (bokmål)‬</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Fluoksetyna">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Fluoxetina">Português</a></li>
				<li class="interwiki-ru"><a href="http://ru.wikipedia.org/wiki/%D0%A4%D0%BB%D1%83%D0%BE%D0%BA%D1%81%D0%B5%D1%82%D0%B8%D0%BD">Русский</a></li>
				<li class="interwiki-simple"><a href="http://simple.wikipedia.org/wiki/Fluoxetine">Simple English</a></li>
				<li class="interwiki-fi"><a href="http://fi.wikipedia.org/wiki/Fluoksetiini">Suomi</a></li>
				<li class="interwiki-sv"><a href="http://sv.wikipedia.org/wiki/Fluoxetin">Svenska</a></li>
				<li class="interwiki-tr"><a href="http://tr.wikipedia.org/wiki/Fluoksetin">Türkçe</a></li>
				<li class="interwiki-zh"><a href="http://zh.wikipedia.org/wiki/%E6%B0%9F%E8%A5%BF%E6%B1%80">中文</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 4 April 2009, at 18:33.</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv217 in 0.048 secs. --></body></html>
